Gene Symbol | Gene ID | Gene Info |
---|---|---|
Pou5f1
|
ENSMUSG00000024406.10 | POU domain, class 5, transcription factor 1 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Pou5f1 | mm10_chr17_35135082_35135254 | -0.21 | 1.3e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr3_88222179_88222410 | 40.04 |
Gm3764 |
predicted gene 3764 |
370 |
0.69 |
chr12_65216407_65216643 | 30.14 |
Gm31063 |
predicted gene, 31063 |
3024 |
0.2 |
chr9_103504692_103504887 | 30.12 |
Tmem108 |
transmembrane protein 108 |
11178 |
0.11 |
chr3_123810123_123810442 | 27.94 |
Gm15400 |
predicted gene 15400 |
48955 |
0.14 |
chr6_112885546_112885750 | 26.85 |
Srgap3 |
SLIT-ROBO Rho GTPase activating protein 3 |
56189 |
0.1 |
chr15_34824497_34824736 | 26.31 |
Gm48932 |
predicted gene, 48932 |
1813 |
0.39 |
chr13_84065521_84065798 | 25.67 |
Gm17750 |
predicted gene, 17750 |
887 |
0.64 |
chr18_47647631_47647996 | 24.58 |
Gm5236 |
predicted gene 5236 |
81954 |
0.08 |
chr8_100516007_100516194 | 24.11 |
Gm45296 |
predicted gene 45296 |
77342 |
0.12 |
chr5_62205496_62205651 | 23.34 |
Gm22273 |
predicted gene, 22273 |
73089 |
0.13 |
chr12_3236518_3237725 | 23.28 |
Rab10os |
RAB10, member RAS oncogene family, opposite strand |
510 |
0.74 |
chr4_28967667_28967925 | 22.54 |
Epha7 |
Eph receptor A7 |
95872 |
0.07 |
chr14_14350947_14351733 | 22.49 |
Il3ra |
interleukin 3 receptor, alpha chain |
1719 |
0.23 |
chr1_168908656_168908844 | 22.38 |
Mir6354 |
microRNA 6354 |
110339 |
0.07 |
chr2_30737839_30738040 | 22.09 |
Mir3089 |
microRNA 3089 |
16729 |
0.13 |
chr3_34411277_34411428 | 22.04 |
Gm34599 |
predicted gene, 34599 |
5143 |
0.21 |
chr4_153929018_153929198 | 21.98 |
BC039966 |
cDNA sequence BC039966 |
21395 |
0.11 |
chr9_103146716_103147058 | 21.83 |
Gm37166 |
predicted gene, 37166 |
26519 |
0.13 |
chr4_81566140_81566319 | 21.68 |
Gm11765 |
predicted gene 11765 |
104497 |
0.07 |
chr19_41164447_41164691 | 21.12 |
Tll2 |
tolloid-like 2 |
42205 |
0.16 |
chr2_152050523_152051049 | 21.01 |
AA387200 |
expressed sequence AA387200 |
26022 |
0.12 |
chr3_134238901_134239307 | 20.94 |
Gm26691 |
predicted gene, 26691 |
1390 |
0.23 |
chr11_77926388_77926572 | 20.86 |
Gm11190 |
predicted gene 11190 |
2808 |
0.18 |
chr10_87420178_87420399 | 20.81 |
Gm23191 |
predicted gene, 23191 |
56142 |
0.12 |
chr9_60460386_60460571 | 20.77 |
Thsd4 |
thrombospondin, type I, domain containing 4 |
36648 |
0.12 |
chr8_30924151_30924556 | 20.43 |
Gm45252 |
predicted gene 45252 |
79555 |
0.1 |
chr1_89739598_89739966 | 19.67 |
Agap1 |
ArfGAP with GTPase domain, ankyrin repeat and PH domain 1 |
49381 |
0.14 |
chr5_133718792_133719001 | 19.66 |
Gm36667 |
predicted gene, 36667 |
120490 |
0.06 |
chr9_58355362_58355540 | 19.50 |
Tbc1d21 |
TBC1 domain family, member 21 |
14918 |
0.15 |
chr13_84906124_84906297 | 19.13 |
Gm4059 |
predicted gene 4059 |
68107 |
0.12 |
chr5_120050815_120050966 | 18.73 |
n-R5s176 |
nuclear encoded rRNA 5S 176 |
13445 |
0.21 |
chr12_11436128_11436416 | 18.63 |
Vsnl1 |
visinin-like 1 |
341 |
0.84 |
chr2_63963866_63964056 | 18.32 |
Fign |
fidgetin |
134027 |
0.06 |
chr9_45434245_45434428 | 17.81 |
4833428L15Rik |
RIKEN cDNA 4833428L15 gene |
2606 |
0.19 |
chr10_95619676_95619912 | 17.79 |
Gm33336 |
predicted gene, 33336 |
12445 |
0.13 |
chr2_105674521_105675719 | 17.68 |
Pax6 |
paired box 6 |
11 |
0.97 |
chr16_64069102_64069325 | 17.67 |
Gm49627 |
predicted gene, 49627 |
114083 |
0.07 |
chr13_83734346_83734573 | 17.62 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
1893 |
0.22 |
chr3_66326110_66326323 | 17.61 |
Veph1 |
ventricular zone expressed PH domain-containing 1 |
29379 |
0.18 |
chr2_48629270_48629461 | 17.25 |
Gm13481 |
predicted gene 13481 |
172120 |
0.03 |
chr16_41771843_41772245 | 17.22 |
Lsamp |
limbic system-associated membrane protein |
238625 |
0.02 |
chr2_57378479_57378900 | 17.19 |
Gm13531 |
predicted gene 13531 |
47020 |
0.16 |
chr3_21672509_21672900 | 17.13 |
Gm17935 |
predicted gene, 17935 |
24317 |
0.19 |
chr7_118992569_118993054 | 17.08 |
Gprc5b |
G protein-coupled receptor, family C, group 5, member B |
2400 |
0.3 |
chr11_77925941_77926251 | 17.05 |
Gm11190 |
predicted gene 11190 |
3192 |
0.17 |
chr10_92555827_92556000 | 17.04 |
Gm4800 |
predicted gene 4800 |
12243 |
0.16 |
chr12_41485289_41485460 | 16.96 |
Lrrn3 |
leucine rich repeat protein 3, neuronal |
1057 |
0.59 |
chr3_8866082_8866744 | 16.88 |
Gm15467 |
predicted gene 15467 |
14786 |
0.17 |
chr2_37516894_37517474 | 16.66 |
Gpr21 |
G protein-coupled receptor 21 |
558 |
0.48 |
chr3_145640287_145640471 | 16.60 |
Ccn1 |
cellular communication network factor 1 |
9602 |
0.18 |
chr13_47414261_47414412 | 16.42 |
Gm35733 |
predicted gene, 35733 |
52950 |
0.15 |
chr10_87489292_87489542 | 16.37 |
Ascl1 |
achaete-scute family bHLH transcription factor 1 |
4243 |
0.23 |
chr2_18041114_18041668 | 16.17 |
Skida1 |
SKI/DACH domain containing 1 |
3181 |
0.14 |
chr13_84399447_84399679 | 16.09 |
Gm26927 |
predicted gene, 26927 |
59450 |
0.13 |
chr7_73197285_73197516 | 15.92 |
Gm20083 |
predicted gene, 20083 |
11597 |
0.16 |
chr3_82357720_82358129 | 15.84 |
Map9 |
microtubule-associated protein 9 |
120 |
0.98 |
chr2_137939077_137939470 | 15.75 |
Gm14062 |
predicted gene 14062 |
62442 |
0.16 |
chr18_25590199_25590989 | 15.73 |
Gm3227 |
predicted gene 3227 |
6896 |
0.29 |
chr13_84059070_84059621 | 15.71 |
Gm17750 |
predicted gene, 17750 |
5427 |
0.24 |
chr13_83869057_83869227 | 15.63 |
2810049E08Rik |
RIKEN cDNA 2810049E08 gene |
22066 |
0.18 |
chr16_91304460_91304617 | 15.62 |
Gm15966 |
predicted gene 15966 |
21202 |
0.11 |
chr12_14927661_14927858 | 15.57 |
Gm9202 |
predicted gene 9202 |
2348 |
0.36 |
chr9_36821327_36821662 | 15.37 |
Fez1 |
fasciculation and elongation protein zeta 1 (zygin I) |
370 |
0.82 |
chr13_77046547_77046698 | 15.36 |
Slf1 |
SMC5-SMC6 complex localization factor 1 |
775 |
0.75 |
chrX_42343522_42343895 | 15.30 |
Gm14619 |
predicted gene 14619 |
3804 |
0.34 |
chr18_25999104_25999542 | 15.24 |
Gm33228 |
predicted gene, 33228 |
8234 |
0.31 |
chr7_73644446_73644645 | 15.21 |
Gm26176 |
predicted gene, 26176 |
1544 |
0.23 |
chr2_146302351_146302690 | 15.20 |
Gm14117 |
predicted gene 14117 |
3027 |
0.28 |
chr6_138420273_138420927 | 15.20 |
Lmo3 |
LIM domain only 3 |
852 |
0.59 |
chr12_50709333_50709681 | 14.94 |
Gm48779 |
predicted gene, 48779 |
43590 |
0.18 |
chr10_37779734_37779887 | 14.89 |
Gm24710 |
predicted gene, 24710 |
151870 |
0.04 |
chr2_51753317_51753685 | 14.89 |
Gm13490 |
predicted gene 13490 |
21492 |
0.21 |
chr12_70070898_70071250 | 14.86 |
Nin |
ninein |
19543 |
0.14 |
chr12_90132535_90132958 | 14.75 |
Gm48700 |
predicted gene, 48700 |
64647 |
0.14 |
chr18_23394845_23395028 | 14.72 |
Dtna |
dystrobrevin alpha |
20199 |
0.27 |
chr16_85092305_85093056 | 14.70 |
Gm49227 |
predicted gene, 49227 |
12569 |
0.2 |
chr13_84565715_84565948 | 14.68 |
Gm26913 |
predicted gene, 26913 |
125110 |
0.06 |
chr3_120983524_120983808 | 14.62 |
Gm43444 |
predicted gene 43444 |
37110 |
0.17 |
chr7_46103268_46103704 | 14.62 |
Abcc8 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 8 |
2347 |
0.15 |
chr1_168269287_168269496 | 14.55 |
Gm37524 |
predicted gene, 37524 |
68280 |
0.12 |
chr13_26656976_26657325 | 14.44 |
Gm47883 |
predicted gene, 47883 |
23543 |
0.23 |
chr16_77685559_77685884 | 14.37 |
Gm37694 |
predicted gene, 37694 |
444 |
0.75 |
chr16_89538151_89538450 | 14.28 |
Krtap7-1 |
keratin associated protein 7-1 |
29977 |
0.13 |
chr8_23562129_23562317 | 14.20 |
Zmat4 |
zinc finger, matrin type 4 |
73796 |
0.11 |
chr8_16057731_16057906 | 14.18 |
Csmd1 |
CUB and Sushi multiple domains 1 |
73006 |
0.12 |
chr9_92930513_92930898 | 14.15 |
Gm28054 |
predicted gene 28054 |
34873 |
0.17 |
chr14_64595318_64595919 | 14.07 |
Mir3078 |
microRNA 3078 |
4433 |
0.18 |
chr18_21422774_21422985 | 14.03 |
Gm22886 |
predicted gene, 22886 |
41948 |
0.15 |
chr8_5918032_5918488 | 13.94 |
Gm2734 |
predicted gene 2734 |
76463 |
0.11 |
chr12_117344591_117345571 | 13.94 |
Gm5441 |
predicted gene 5441 |
8059 |
0.29 |
chr6_10970256_10970438 | 13.88 |
AA545190 |
EST AA545190 |
4031 |
0.31 |
chr1_194746751_194747168 | 13.86 |
2900035J10Rik |
RIKEN cDNA 2900035J10 gene |
14252 |
0.16 |
chr18_52847997_52848328 | 13.83 |
Sncaip |
synuclein, alpha interacting protein (synphilin) |
10152 |
0.23 |
chr10_46827266_46827417 | 13.81 |
Gm25650 |
predicted gene, 25650 |
11166 |
0.24 |
chr6_77979020_77979189 | 13.78 |
Ctnna2 |
catenin (cadherin associated protein), alpha 2 |
446 |
0.85 |
chr1_96346717_96347057 | 13.74 |
Gm37076 |
predicted gene, 37076 |
33645 |
0.18 |
chr4_140505707_140505858 | 13.67 |
Gm50453 |
predicted gene, 50453 |
59618 |
0.09 |
chr4_136905224_136905433 | 13.66 |
C1qa |
complement component 1, q subcomponent, alpha polypeptide |
6525 |
0.16 |
chr13_83749525_83749738 | 13.54 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
10768 |
0.12 |
chr4_110050502_110051534 | 13.44 |
Dmrta2 |
doublesex and mab-3 related transcription factor like family A2 |
72965 |
0.11 |
chr6_31948254_31948407 | 13.36 |
1700012A03Rik |
RIKEN cDNA 1700012A03 gene |
101916 |
0.07 |
chr9_45663374_45663610 | 13.35 |
Dscaml1 |
DS cell adhesion molecule like 1 |
9345 |
0.19 |
chr1_77496756_77497303 | 13.32 |
Mir6352 |
microRNA 6352 |
261 |
0.92 |
chr17_56552225_56552791 | 13.28 |
Gm20219 |
predicted gene, 20219 |
1879 |
0.23 |
chr5_82898629_82898780 | 13.28 |
Gm24129 |
predicted gene, 24129 |
94939 |
0.08 |
chr5_97289764_97289960 | 13.26 |
Gm5560 |
predicted pseudogene 5560 |
25034 |
0.17 |
chr2_45225367_45225747 | 13.23 |
Gm28643 |
predicted gene 28643 |
68632 |
0.11 |
chr4_155024880_155025031 | 13.22 |
Plch2 |
phospholipase C, eta 2 |
5523 |
0.14 |
chr3_141691878_141692233 | 13.16 |
Gm43826 |
predicted gene 43826 |
5502 |
0.25 |
chr5_77838512_77838806 | 13.12 |
Gm42673 |
predicted gene 42673 |
70801 |
0.12 |
chr8_54954036_54954355 | 13.12 |
Gpm6a |
glycoprotein m6a |
648 |
0.67 |
chr1_82452012_82452232 | 13.11 |
Gm28940 |
predicted gene 28940 |
49376 |
0.12 |
chr7_70129967_70130397 | 13.07 |
Gm35325 |
predicted gene, 35325 |
77253 |
0.1 |
chrX_22898443_22898628 | 13.06 |
Gm26131 |
predicted gene, 26131 |
36599 |
0.24 |
chr6_91839077_91839294 | 13.05 |
Grip2 |
glutamate receptor interacting protein 2 |
11935 |
0.16 |
chr13_85067295_85067464 | 12.94 |
Gm47745 |
predicted gene, 47745 |
26956 |
0.17 |
chr9_35402474_35402797 | 12.92 |
Cdon |
cell adhesion molecule-related/down-regulated by oncogenes |
18493 |
0.14 |
chr2_51066438_51066648 | 12.87 |
Rnd3 |
Rho family GTPase 3 |
82551 |
0.1 |
chr14_12338097_12338549 | 12.86 |
Gm24578 |
predicted gene, 24578 |
4419 |
0.14 |
chr5_51412279_51412789 | 12.78 |
Gm42614 |
predicted gene 42614 |
71771 |
0.1 |
chr1_97622935_97623105 | 12.72 |
AC099860.1 |
proline rich protein BstNI subfamily 4 (PRB4), pseudogene |
37811 |
0.15 |
chr16_33605736_33606716 | 12.68 |
Slc12a8 |
solute carrier family 12 (potassium/chloride transporters), member 8 |
9599 |
0.26 |
chr13_110115255_110115618 | 12.67 |
Rab3c |
RAB3C, member RAS oncogene family |
164714 |
0.04 |
chr2_82847422_82847589 | 12.67 |
Fsip2 |
fibrous sheath-interacting protein 2 |
96129 |
0.09 |
chr6_107531586_107531766 | 12.50 |
Lrrn1 |
leucine rich repeat protein 1, neuronal |
1908 |
0.39 |
chr14_51385717_51386130 | 12.48 |
Vmn2r-ps111 |
vomeronasal 2, receptor, pseudogene 111 |
8575 |
0.09 |
chr16_72222039_72222224 | 12.47 |
8030451O07Rik |
RIKEN cDNA 8030451O07 gene |
12171 |
0.29 |
chr7_119088115_119088300 | 12.45 |
Gprc5b |
G protein-coupled receptor, family C, group 5, member B |
92996 |
0.07 |
chr3_127868927_127869254 | 12.42 |
Gm43652 |
predicted gene 43652 |
5232 |
0.12 |
chr11_118793380_118793549 | 12.36 |
Gm11750 |
predicted gene 11750 |
2092 |
0.33 |
chr6_91345867_91346380 | 12.31 |
Wnt7a |
wingless-type MMTV integration site family, member 7A |
18948 |
0.15 |
chr5_26991582_26992107 | 12.27 |
Gm16057 |
predicted gene 16057 |
15777 |
0.25 |
chr4_28143373_28143526 | 12.25 |
Gm11911 |
predicted gene 11911 |
76272 |
0.11 |
chr12_46646443_46646754 | 12.24 |
Gm48535 |
predicted gene, 48535 |
19111 |
0.16 |
chr14_74113188_74113446 | 12.22 |
Gm49170 |
predicted gene, 49170 |
139091 |
0.04 |
chr16_71496703_71496854 | 12.22 |
Gm22797 |
predicted gene, 22797 |
167010 |
0.04 |
chr2_12329756_12329928 | 12.14 |
Mindy3 |
MINDY lysine 48 deubiquitinase 3 |
27069 |
0.12 |
chr2_22029338_22029851 | 12.11 |
Gm13337 |
predicted gene 13337 |
38232 |
0.22 |
chr16_69469628_69469791 | 12.11 |
4930428D20Rik |
RIKEN cDNA 4930428D20 gene |
330672 |
0.01 |
chr6_55484275_55484600 | 12.09 |
Adcyap1r1 |
adenylate cyclase activating polypeptide 1 receptor 1 |
24201 |
0.19 |
chr18_26941794_26941973 | 12.07 |
Gm26106 |
predicted gene, 26106 |
13554 |
0.21 |
chr16_28752897_28753619 | 12.07 |
Fgf12 |
fibroblast growth factor 12 |
190 |
0.97 |
chr1_42877296_42877582 | 12.06 |
Mrps9 |
mitochondrial ribosomal protein S9 |
10298 |
0.19 |
chr18_46067126_46067291 | 12.05 |
A330093E20Rik |
RIKEN cDNA A330093E20 gene |
21948 |
0.2 |
chr6_8422220_8422401 | 12.05 |
Umad1 |
UMAP1-MVP12 associated (UMA) domain containing 1 |
2632 |
0.24 |
chr13_119741850_119742224 | 12.04 |
Nim1k |
NIM1 serine/threonine protein kinase |
3643 |
0.15 |
chr7_139545075_139545281 | 12.04 |
Inpp5a |
inositol polyphosphate-5-phosphatase A |
21320 |
0.18 |
chr5_42270789_42270940 | 12.04 |
Gm16223 |
predicted gene 16223 |
202904 |
0.03 |
chr9_36821980_36822332 | 12.02 |
Fez1 |
fasciculation and elongation protein zeta 1 (zygin I) |
292 |
0.87 |
chr5_106560658_106561014 | 12.02 |
Gm28050 |
predicted gene, 28050 |
13879 |
0.14 |
chr2_10737503_10737690 | 12.00 |
Gm18547 |
predicted gene, 18547 |
156113 |
0.01 |
chr13_18856177_18856400 | 11.98 |
Vps41 |
VPS41 HOPS complex subunit |
11425 |
0.23 |
chr5_75013200_75013361 | 11.97 |
Gm42576 |
predicted gene 42576 |
9801 |
0.14 |
chr2_115725187_115725338 | 11.86 |
Mir1951 |
microRNA 1951 |
86537 |
0.09 |
chr6_138419688_138419839 | 11.82 |
Lmo3 |
LIM domain only 3 |
1689 |
0.36 |
chr11_112826261_112826412 | 11.82 |
4933434M16Rik |
RIKEN cDNA 4933434M16 gene |
1157 |
0.52 |
chr8_109252441_109252632 | 11.81 |
D030068K23Rik |
RIKEN cDNA D030068K23 gene |
2670 |
0.38 |
chr4_31727820_31728120 | 11.81 |
Map3k7 |
mitogen-activated protein kinase kinase kinase 7 |
236127 |
0.02 |
chr15_30383087_30383401 | 11.80 |
Gm49283 |
predicted gene, 49283 |
45600 |
0.17 |
chr3_144411063_144411292 | 11.79 |
Gm5857 |
predicted gene 5857 |
16495 |
0.21 |
chr12_12323469_12324268 | 11.77 |
Fam49a |
family with sequence similarity 49, member A |
61679 |
0.13 |
chr3_85299790_85299992 | 11.75 |
1700036G14Rik |
RIKEN cDNA 1700036G14 gene |
17628 |
0.24 |
chr13_85068402_85068695 | 11.75 |
Gm47745 |
predicted gene, 47745 |
25787 |
0.17 |
chr8_78556826_78557206 | 11.75 |
Slc10a7 |
solute carrier family 10 (sodium/bile acid cotransporter family), member 7 |
20735 |
0.18 |
chr10_115469021_115469459 | 11.73 |
Lgr5 |
leucine rich repeat containing G protein coupled receptor 5 |
6161 |
0.21 |
chr4_25408601_25409020 | 11.73 |
Gm11894 |
predicted gene 11894 |
10539 |
0.22 |
chr9_16484808_16485485 | 11.69 |
Fat3 |
FAT atypical cadherin 3 |
16139 |
0.27 |
chr6_6603963_6604155 | 11.68 |
Sem1 |
SEM1, 26S proteasome complex subunit |
25396 |
0.18 |
chr12_37988361_37988598 | 11.67 |
Dgkb |
diacylglycerol kinase, beta |
29235 |
0.2 |
chr4_41470681_41471126 | 11.66 |
Nudt2 |
nudix (nucleoside diphosphate linked moiety X)-type motif 2 |
5752 |
0.12 |
chr10_18469268_18469623 | 11.64 |
Nhsl1 |
NHS-like 1 |
443 |
0.87 |
chr2_51038826_51038996 | 11.63 |
Rnd3 |
Rho family GTPase 3 |
110183 |
0.06 |
chr6_114329658_114329887 | 11.58 |
Slc6a1 |
solute carrier family 6 (neurotransmitter transporter, GABA), member 1 |
16483 |
0.24 |
chr4_86183975_86184194 | 11.58 |
Adamtsl1 |
ADAMTS-like 1 |
15233 |
0.29 |
chr6_93792421_93792585 | 11.58 |
Magi1 |
membrane associated guanylate kinase, WW and PDZ domain containing 1 |
36 |
0.97 |
chr11_34276626_34277049 | 11.53 |
4930403D09Rik |
RIKEN cDNA 4930403D09 gene |
22870 |
0.17 |
chr1_58046960_58047141 | 11.53 |
Aox1 |
aldehyde oxidase 1 |
17086 |
0.16 |
chr15_62284637_62284934 | 11.45 |
Pvt1 |
Pvt1 oncogene |
62182 |
0.13 |
chr3_34521806_34521966 | 11.43 |
Sox2ot |
SOX2 overlapping transcript (non-protein coding) |
38442 |
0.12 |
chr12_10875269_10875443 | 11.42 |
Pgk1-rs7 |
phosphoglycerate kinase-1, related sequence-7 |
24884 |
0.23 |
chr5_131794362_131794585 | 11.41 |
4930563F08Rik |
RIKEN cDNA 4930563F08 gene |
85796 |
0.06 |
chr16_43800088_43800449 | 11.40 |
Gm25996 |
predicted gene, 25996 |
2851 |
0.23 |
chr6_103944408_103944702 | 11.39 |
Gm21054 |
predicted gene, 21054 |
20084 |
0.27 |
chr10_16157127_16157278 | 11.39 |
Gm18557 |
predicted gene, 18557 |
207596 |
0.02 |
chr4_64148922_64149333 | 11.38 |
8030451A03Rik |
RIKEN cDNA 8030451A03 gene |
574 |
0.83 |
chr16_78827842_78828020 | 11.37 |
4930403O18Rik |
RIKEN cDNA 4930403O18 gene |
70198 |
0.11 |
chr4_30855756_30855939 | 11.37 |
Gm11920 |
predicted gene 11920 |
153312 |
0.04 |
chr8_45558513_45558673 | 11.36 |
Gm45458 |
predicted gene 45458 |
18478 |
0.16 |
chr1_125351456_125351634 | 11.32 |
Actr3 |
ARP3 actin-related protein 3 |
46067 |
0.18 |
chr11_25854231_25854525 | 11.32 |
5730522E02Rik |
RIKEN cDNA 5730522E02 gene |
85237 |
0.11 |
chrX_110811168_110811444 | 11.29 |
Gm44593 |
predicted gene 44593 |
1018 |
0.58 |
chr8_33747700_33747868 | 11.27 |
Smim18 |
small integral membrane protein 18 |
14 |
0.97 |
chr16_66969715_66969926 | 11.25 |
Cadm2 |
cell adhesion molecule 2 |
16486 |
0.28 |
chr9_107486045_107486460 | 11.22 |
Cacna2d2 |
calcium channel, voltage-dependent, alpha 2/delta subunit 2 |
19352 |
0.08 |
chr18_74956688_74957137 | 11.18 |
Lipg |
lipase, endothelial |
4350 |
0.11 |
chr5_44698439_44698590 | 11.17 |
Gm3364 |
predicted gene 3364 |
8376 |
0.14 |
chr6_127405680_127406116 | 11.15 |
Gm34091 |
predicted gene, 34091 |
5232 |
0.18 |
chr6_85320380_85320887 | 11.10 |
Sfxn5 |
sideroflexin 5 |
235 |
0.91 |
chr4_110152119_110152431 | 11.08 |
Elavl4 |
ELAV like RNA binding protein 4 |
70873 |
0.12 |
chr7_122478149_122478324 | 11.07 |
Gm14389 |
predicted gene 14389 |
6184 |
0.17 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.9 | 20.7 | GO:0021912 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) |
6.8 | 47.3 | GO:0098596 | vocal learning(GO:0042297) imitative learning(GO:0098596) learned vocalization behavior or vocal learning(GO:0098598) |
4.3 | 13.0 | GO:0070649 | formin-nucleated actin cable assembly(GO:0070649) |
4.2 | 16.9 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
4.0 | 12.1 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
4.0 | 11.9 | GO:0034184 | positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
3.6 | 10.8 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
3.6 | 7.2 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
3.5 | 10.4 | GO:2000302 | positive regulation of synaptic vesicle exocytosis(GO:2000302) |
3.4 | 10.1 | GO:0006842 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
3.2 | 9.5 | GO:0021856 | cerebral cortex tangential migration using cell-axon interactions(GO:0021824) gonadotrophin-releasing hormone neuronal migration to the hypothalamus(GO:0021828) hypothalamic tangential migration using cell-axon interactions(GO:0021856) facioacoustic ganglion development(GO:1903375) |
3.1 | 15.7 | GO:0071698 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
3.0 | 9.0 | GO:0048677 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
3.0 | 11.9 | GO:0051612 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
3.0 | 11.8 | GO:1903818 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) positive regulation of voltage-gated potassium channel activity(GO:1903818) |
2.9 | 8.8 | GO:0003358 | noradrenergic neuron development(GO:0003358) |
2.9 | 23.4 | GO:0021830 | interneuron migration from the subpallium to the cortex(GO:0021830) |
2.7 | 24.4 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
2.7 | 10.8 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
2.6 | 5.3 | GO:0021827 | cerebral cortex tangential migration using cell-cell interactions(GO:0021823) postnatal olfactory bulb interneuron migration(GO:0021827) |
2.5 | 5.0 | GO:0031223 | auditory behavior(GO:0031223) |
2.4 | 7.3 | GO:0021847 | ventricular zone neuroblast division(GO:0021847) |
2.1 | 4.3 | GO:1901841 | regulation of high voltage-gated calcium channel activity(GO:1901841) |
2.1 | 6.4 | GO:0061091 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
2.1 | 18.7 | GO:0048671 | negative regulation of collateral sprouting(GO:0048671) |
2.1 | 6.2 | GO:0099558 | maintenance of synapse structure(GO:0099558) |
2.0 | 6.1 | GO:0003357 | noradrenergic neuron differentiation(GO:0003357) |
1.9 | 5.8 | GO:0032025 | response to cobalt ion(GO:0032025) |
1.9 | 5.8 | GO:0006553 | lysine metabolic process(GO:0006553) |
1.9 | 13.4 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
1.9 | 5.7 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
1.9 | 5.7 | GO:0006046 | N-acetylglucosamine catabolic process(GO:0006046) |
1.8 | 5.5 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
1.8 | 3.6 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
1.8 | 5.4 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
1.7 | 12.2 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
1.7 | 1.7 | GO:0045048 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
1.7 | 13.3 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
1.7 | 6.6 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
1.6 | 4.8 | GO:2000857 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
1.6 | 4.8 | GO:0071503 | response to heparin(GO:0071503) cellular response to heparin(GO:0071504) |
1.6 | 3.1 | GO:1904430 | negative regulation of t-circle formation(GO:1904430) |
1.6 | 4.7 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
1.6 | 4.7 | GO:1904378 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
1.6 | 10.9 | GO:0010649 | regulation of cell communication by electrical coupling(GO:0010649) |
1.5 | 3.1 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
1.5 | 7.6 | GO:1904398 | positive regulation of neuromuscular junction development(GO:1904398) |
1.5 | 4.6 | GO:0072092 | ureteric bud invasion(GO:0072092) |
1.5 | 10.5 | GO:0097264 | self proteolysis(GO:0097264) |
1.5 | 5.9 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
1.5 | 4.4 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
1.5 | 4.4 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
1.5 | 5.8 | GO:0016199 | axon midline choice point recognition(GO:0016199) |
1.4 | 2.9 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
1.4 | 2.8 | GO:2001016 | positive regulation of skeletal muscle cell differentiation(GO:2001016) |
1.4 | 4.1 | GO:2000211 | regulation of glutamate metabolic process(GO:2000211) |
1.4 | 4.1 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
1.4 | 2.8 | GO:1903261 | regulation of serine phosphorylation of STAT3 protein(GO:1903261) |
1.4 | 4.1 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
1.4 | 4.1 | GO:0002877 | regulation of acute inflammatory response to non-antigenic stimulus(GO:0002877) |
1.3 | 2.7 | GO:0070672 | response to interleukin-15(GO:0070672) |
1.3 | 2.6 | GO:0051665 | membrane raft localization(GO:0051665) |
1.3 | 7.9 | GO:1902222 | L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
1.3 | 13.1 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
1.3 | 3.9 | GO:0007412 | axon target recognition(GO:0007412) |
1.3 | 5.2 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
1.3 | 21.9 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
1.3 | 2.6 | GO:0016198 | axon choice point recognition(GO:0016198) |
1.3 | 11.4 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
1.3 | 6.3 | GO:0048496 | maintenance of organ identity(GO:0048496) |
1.3 | 3.8 | GO:0046544 | development of secondary male sexual characteristics(GO:0046544) |
1.3 | 8.8 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
1.3 | 3.8 | GO:1990034 | calcium ion export from cell(GO:1990034) |
1.2 | 1.2 | GO:0042668 | auditory receptor cell fate determination(GO:0042668) |
1.2 | 1.2 | GO:0061346 | non-canonical Wnt signaling pathway involved in heart development(GO:0061341) planar cell polarity pathway involved in heart morphogenesis(GO:0061346) |
1.2 | 4.7 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
1.2 | 5.8 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
1.2 | 1.2 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
1.1 | 3.4 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
1.1 | 8.0 | GO:0090394 | negative regulation of excitatory postsynaptic potential(GO:0090394) |
1.1 | 7.9 | GO:0014054 | positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
1.1 | 6.8 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
1.1 | 3.4 | GO:2000474 | regulation of opioid receptor signaling pathway(GO:2000474) |
1.1 | 4.5 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
1.1 | 3.3 | GO:0048807 | female genitalia morphogenesis(GO:0048807) |
1.1 | 4.4 | GO:0008655 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
1.1 | 3.3 | GO:0032474 | otolith morphogenesis(GO:0032474) |
1.1 | 2.2 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
1.1 | 6.3 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
1.0 | 91.3 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
1.0 | 3.1 | GO:0030070 | insulin processing(GO:0030070) |
1.0 | 4.2 | GO:0032497 | detection of lipopolysaccharide(GO:0032497) |
1.0 | 2.1 | GO:0042322 | negative regulation of circadian sleep/wake cycle, REM sleep(GO:0042322) |
1.0 | 9.3 | GO:0034331 | cell junction maintenance(GO:0034331) |
1.0 | 11.3 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
1.0 | 3.0 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
1.0 | 3.0 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
1.0 | 3.0 | GO:0006210 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
1.0 | 3.0 | GO:0048023 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
1.0 | 2.0 | GO:0021530 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
1.0 | 3.0 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
1.0 | 1.0 | GO:0097476 | motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
1.0 | 14.8 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
1.0 | 2.0 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
1.0 | 5.9 | GO:0090527 | actin filament reorganization(GO:0090527) |
1.0 | 2.0 | GO:0089700 | protein kinase D signaling(GO:0089700) |
1.0 | 7.7 | GO:0070986 | left/right axis specification(GO:0070986) |
0.9 | 1.9 | GO:2000041 | regulation of planar cell polarity pathway involved in axis elongation(GO:2000040) negative regulation of planar cell polarity pathway involved in axis elongation(GO:2000041) |
0.9 | 2.8 | GO:0060066 | oviduct development(GO:0060066) |
0.9 | 2.8 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.9 | 1.8 | GO:0060166 | olfactory pit development(GO:0060166) |
0.9 | 8.0 | GO:2000671 | regulation of motor neuron apoptotic process(GO:2000671) |
0.9 | 4.4 | GO:0090240 | positive regulation of histone H4 acetylation(GO:0090240) |
0.9 | 47.0 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.9 | 4.4 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.9 | 0.9 | GO:0033239 | negative regulation of cellular amine metabolic process(GO:0033239) |
0.9 | 4.4 | GO:0044332 | Wnt signaling pathway involved in dorsal/ventral axis specification(GO:0044332) |
0.9 | 3.5 | GO:0038108 | negative regulation of appetite by leptin-mediated signaling pathway(GO:0038108) |
0.9 | 2.6 | GO:0046103 | inosine biosynthetic process(GO:0046103) |
0.9 | 3.5 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
0.8 | 2.5 | GO:0042253 | granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0042253) regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045423) |
0.8 | 2.5 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
0.8 | 9.0 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
0.8 | 2.4 | GO:0015803 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.8 | 2.4 | GO:0060729 | intestinal epithelial structure maintenance(GO:0060729) |
0.8 | 8.1 | GO:0045779 | negative regulation of bone resorption(GO:0045779) |
0.8 | 3.2 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
0.8 | 2.4 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
0.8 | 2.4 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
0.8 | 2.4 | GO:0060584 | regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
0.8 | 4.0 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
0.8 | 0.8 | GO:0046684 | response to pyrethroid(GO:0046684) |
0.8 | 3.2 | GO:0071877 | regulation of adrenergic receptor signaling pathway(GO:0071877) |
0.8 | 3.1 | GO:0060605 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
0.8 | 7.9 | GO:0097120 | receptor localization to synapse(GO:0097120) |
0.8 | 5.5 | GO:0021860 | pyramidal neuron development(GO:0021860) |
0.8 | 1.6 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.8 | 3.1 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.8 | 3.1 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.8 | 3.8 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.8 | 7.6 | GO:0007191 | adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
0.8 | 3.1 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
0.8 | 2.3 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.7 | 17.9 | GO:0035774 | positive regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0035774) |
0.7 | 3.7 | GO:0071372 | cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
0.7 | 8.2 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.7 | 1.5 | GO:0034196 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
0.7 | 2.2 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.7 | 15.4 | GO:0051491 | positive regulation of filopodium assembly(GO:0051491) |
0.7 | 5.9 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
0.7 | 2.2 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.7 | 2.2 | GO:0090292 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.7 | 3.6 | GO:0030205 | dermatan sulfate metabolic process(GO:0030205) |
0.7 | 1.4 | GO:0043134 | hindgut contraction(GO:0043133) regulation of hindgut contraction(GO:0043134) |
0.7 | 2.1 | GO:0035633 | maintenance of blood-brain barrier(GO:0035633) |
0.7 | 0.7 | GO:0021586 | pons maturation(GO:0021586) |
0.7 | 0.7 | GO:0048370 | lateral mesoderm morphogenesis(GO:0048369) lateral mesoderm formation(GO:0048370) lateral mesodermal cell differentiation(GO:0048371) |
0.7 | 9.0 | GO:0032012 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.7 | 8.3 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.7 | 5.5 | GO:0021521 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
0.7 | 2.0 | GO:0090156 | negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) negative regulation of ceramide biosynthetic process(GO:1900060) |
0.7 | 4.8 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
0.7 | 4.0 | GO:1903961 | positive regulation of anion transmembrane transport(GO:1903961) |
0.7 | 1.3 | GO:0008272 | sulfate transport(GO:0008272) |
0.7 | 2.0 | GO:0030242 | pexophagy(GO:0030242) |
0.7 | 4.6 | GO:0098870 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.7 | 4.0 | GO:0015824 | proline transport(GO:0015824) |
0.7 | 1.3 | GO:0097460 | ferrous iron import into cell(GO:0097460) |
0.7 | 2.0 | GO:0022038 | corpus callosum development(GO:0022038) |
0.7 | 3.3 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.6 | 5.2 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
0.6 | 4.5 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
0.6 | 3.2 | GO:0046110 | xanthine catabolic process(GO:0009115) xanthine metabolic process(GO:0046110) |
0.6 | 14.1 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.6 | 1.9 | GO:0034454 | microtubule anchoring at centrosome(GO:0034454) |
0.6 | 5.1 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.6 | 1.9 | GO:0033026 | negative regulation of mast cell apoptotic process(GO:0033026) |
0.6 | 1.3 | GO:0051466 | corticotropin-releasing hormone secretion(GO:0043396) regulation of corticotropin-releasing hormone secretion(GO:0043397) positive regulation of corticotropin-releasing hormone secretion(GO:0051466) |
0.6 | 1.9 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.6 | 2.5 | GO:0006538 | glutamate catabolic process(GO:0006538) |
0.6 | 7.4 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.6 | 2.5 | GO:0021535 | cell migration in hindbrain(GO:0021535) |
0.6 | 2.5 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
0.6 | 4.9 | GO:1900746 | regulation of vascular endothelial growth factor signaling pathway(GO:1900746) |
0.6 | 5.5 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.6 | 2.4 | GO:0042420 | dopamine catabolic process(GO:0042420) |
0.6 | 7.8 | GO:0090036 | regulation of protein kinase C signaling(GO:0090036) |
0.6 | 2.4 | GO:0072015 | glomerular visceral epithelial cell development(GO:0072015) glomerular epithelial cell development(GO:0072310) |
0.6 | 1.2 | GO:0072679 | thymocyte migration(GO:0072679) regulation of thymocyte migration(GO:2000410) positive regulation of thymocyte migration(GO:2000412) |
0.6 | 1.8 | GO:0098910 | regulation of atrial cardiac muscle cell action potential(GO:0098910) |
0.6 | 1.8 | GO:0036233 | glycine import(GO:0036233) |
0.6 | 15.8 | GO:2000649 | regulation of sodium ion transmembrane transporter activity(GO:2000649) |
0.6 | 4.1 | GO:2000258 | negative regulation of complement activation(GO:0045916) negative regulation of protein activation cascade(GO:2000258) |
0.6 | 2.3 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.6 | 2.3 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.6 | 2.3 | GO:0048007 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.6 | 1.1 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.6 | 1.7 | GO:0032066 | nucleolus to nucleoplasm transport(GO:0032066) |
0.6 | 4.5 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.6 | 5.1 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.6 | 1.1 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
0.6 | 1.7 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
0.6 | 1.1 | GO:0021564 | vagus nerve development(GO:0021564) |
0.6 | 2.8 | GO:1900122 | positive regulation of receptor binding(GO:1900122) |
0.6 | 2.8 | GO:0048242 | epinephrine secretion(GO:0048242) |
0.6 | 0.6 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.6 | 2.2 | GO:2000622 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.6 | 3.9 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
0.5 | 2.7 | GO:0021707 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.5 | 3.3 | GO:0060903 | positive regulation of meiosis I(GO:0060903) |
0.5 | 2.2 | GO:0048069 | eye pigmentation(GO:0048069) |
0.5 | 2.7 | GO:1902774 | late endosome to lysosome transport(GO:1902774) |
0.5 | 16.2 | GO:0019228 | neuronal action potential(GO:0019228) |
0.5 | 2.7 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.5 | 1.6 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
0.5 | 3.7 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
0.5 | 2.7 | GO:0050957 | equilibrioception(GO:0050957) |
0.5 | 1.1 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.5 | 1.1 | GO:0003150 | muscular septum morphogenesis(GO:0003150) |
0.5 | 2.6 | GO:0045607 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.5 | 1.6 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
0.5 | 5.7 | GO:0001504 | neurotransmitter uptake(GO:0001504) |
0.5 | 5.2 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
0.5 | 1.0 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
0.5 | 4.1 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
0.5 | 3.1 | GO:0042473 | outer ear morphogenesis(GO:0042473) |
0.5 | 3.0 | GO:0090141 | positive regulation of mitochondrial fission(GO:0090141) |
0.5 | 1.0 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.5 | 1.5 | GO:0042483 | negative regulation of odontogenesis(GO:0042483) |
0.5 | 1.0 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.5 | 2.0 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.5 | 2.5 | GO:2000010 | positive regulation of protein localization to cell surface(GO:2000010) |
0.5 | 2.5 | GO:0036006 | response to macrophage colony-stimulating factor(GO:0036005) cellular response to macrophage colony-stimulating factor stimulus(GO:0036006) |
0.5 | 2.0 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
0.5 | 1.5 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.5 | 8.8 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
0.5 | 2.0 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
0.5 | 0.5 | GO:0098904 | regulation of AV node cell action potential(GO:0098904) |
0.5 | 2.4 | GO:0080009 | mRNA methylation(GO:0080009) |
0.5 | 1.5 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
0.5 | 5.3 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
0.5 | 0.5 | GO:0070343 | white fat cell proliferation(GO:0070343) regulation of white fat cell proliferation(GO:0070350) |
0.5 | 1.0 | GO:1901382 | chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
0.5 | 1.0 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
0.5 | 1.9 | GO:0021999 | neural plate anterior/posterior regionalization(GO:0021999) |
0.5 | 1.9 | GO:0060923 | cardiac muscle cell fate commitment(GO:0060923) |
0.5 | 0.5 | GO:0035880 | embryonic nail plate morphogenesis(GO:0035880) |
0.5 | 1.9 | GO:0046881 | positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
0.5 | 0.9 | GO:0030576 | Cajal body organization(GO:0030576) |
0.5 | 1.9 | GO:0046010 | positive regulation of circadian sleep/wake cycle, non-REM sleep(GO:0046010) |
0.5 | 2.4 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.5 | 2.4 | GO:0097466 | glycoprotein ERAD pathway(GO:0097466) response to glycoprotein(GO:1904587) |
0.5 | 1.4 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
0.5 | 2.8 | GO:0045836 | positive regulation of meiotic nuclear division(GO:0045836) |
0.5 | 1.4 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
0.5 | 2.3 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.5 | 0.5 | GO:0034633 | retinol transport(GO:0034633) isoprenoid transport(GO:0046864) terpenoid transport(GO:0046865) |
0.5 | 0.5 | GO:0072034 | renal vesicle induction(GO:0072034) |
0.5 | 0.9 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
0.5 | 1.8 | GO:0021794 | thalamus development(GO:0021794) |
0.5 | 0.9 | GO:0070571 | negative regulation of neuron projection regeneration(GO:0070571) |
0.5 | 0.9 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.4 | 1.8 | GO:0038031 | non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.4 | 1.8 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
0.4 | 5.3 | GO:2001222 | regulation of neuron migration(GO:2001222) |
0.4 | 0.9 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
0.4 | 0.4 | GO:0001997 | positive regulation of the force of heart contraction by epinephrine-norepinephrine(GO:0001997) positive regulation of the force of heart contraction by chemical signal(GO:0003099) |
0.4 | 3.1 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.4 | 2.2 | GO:0048631 | regulation of skeletal muscle tissue growth(GO:0048631) |
0.4 | 1.3 | GO:0043313 | regulation of neutrophil degranulation(GO:0043313) |
0.4 | 0.9 | GO:0001555 | oocyte growth(GO:0001555) |
0.4 | 3.5 | GO:0060346 | bone trabecula formation(GO:0060346) |
0.4 | 0.9 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
0.4 | 1.3 | GO:0010917 | negative regulation of mitochondrial membrane potential(GO:0010917) |
0.4 | 1.3 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
0.4 | 3.4 | GO:0048245 | eosinophil chemotaxis(GO:0048245) |
0.4 | 1.7 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.4 | 2.1 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
0.4 | 0.4 | GO:0060737 | prostate epithelial cord elongation(GO:0060523) prostate gland morphogenetic growth(GO:0060737) |
0.4 | 1.7 | GO:0070842 | aggresome assembly(GO:0070842) |
0.4 | 1.2 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.4 | 1.6 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
0.4 | 2.8 | GO:0048742 | regulation of skeletal muscle fiber development(GO:0048742) |
0.4 | 3.7 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.4 | 1.2 | GO:1902172 | keratinocyte apoptotic process(GO:0097283) regulation of keratinocyte apoptotic process(GO:1902172) |
0.4 | 1.2 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.4 | 2.0 | GO:0048341 | paraxial mesoderm formation(GO:0048341) |
0.4 | 1.2 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.4 | 1.2 | GO:0001767 | establishment of lymphocyte polarity(GO:0001767) establishment of T cell polarity(GO:0001768) |
0.4 | 0.4 | GO:2000384 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
0.4 | 0.4 | GO:0060264 | regulation of respiratory burst involved in inflammatory response(GO:0060264) negative regulation of respiratory burst involved in inflammatory response(GO:0060266) |
0.4 | 0.8 | GO:0035441 | cell migration involved in vasculogenesis(GO:0035441) |
0.4 | 1.2 | GO:0042851 | L-alanine metabolic process(GO:0042851) |
0.4 | 0.4 | GO:0072602 | interleukin-4 secretion(GO:0072602) |
0.4 | 0.4 | GO:0055005 | ventricular cardiac myofibril assembly(GO:0055005) |
0.4 | 0.4 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
0.4 | 16.4 | GO:1902850 | mitotic spindle assembly(GO:0090307) microtubule cytoskeleton organization involved in mitosis(GO:1902850) |
0.4 | 1.9 | GO:0050966 | detection of mechanical stimulus involved in sensory perception of pain(GO:0050966) |
0.4 | 1.5 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.4 | 10.7 | GO:0045744 | negative regulation of G-protein coupled receptor protein signaling pathway(GO:0045744) |
0.4 | 0.4 | GO:0060459 | left lung development(GO:0060459) |
0.4 | 3.0 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.4 | 3.8 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
0.4 | 1.1 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.4 | 2.6 | GO:0034650 | cortisol metabolic process(GO:0034650) |
0.4 | 1.1 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
0.4 | 1.5 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.4 | 1.8 | GO:0039532 | negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway(GO:0039532) |
0.4 | 2.2 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.4 | 0.7 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
0.4 | 0.4 | GO:0039530 | MDA-5 signaling pathway(GO:0039530) |
0.4 | 0.4 | GO:0061743 | motor learning(GO:0061743) |
0.4 | 2.9 | GO:0010919 | regulation of inositol phosphate biosynthetic process(GO:0010919) |
0.4 | 2.5 | GO:1902855 | regulation of nonmotile primary cilium assembly(GO:1902855) |
0.4 | 0.7 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.4 | 3.6 | GO:0050667 | homocysteine metabolic process(GO:0050667) |
0.4 | 1.4 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.4 | 0.7 | GO:1903999 | negative regulation of eating behavior(GO:1903999) |
0.4 | 2.8 | GO:1904869 | protein localization to nuclear body(GO:1903405) protein localization to Cajal body(GO:1904867) regulation of protein localization to Cajal body(GO:1904869) positive regulation of protein localization to Cajal body(GO:1904871) protein localization to nucleoplasm(GO:1990173) |
0.3 | 0.7 | GO:2001171 | positive regulation of ATP biosynthetic process(GO:2001171) |
0.3 | 0.3 | GO:0033058 | directional locomotion(GO:0033058) |
0.3 | 2.1 | GO:0015884 | folic acid transport(GO:0015884) |
0.3 | 5.1 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
0.3 | 0.7 | GO:0019065 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
0.3 | 1.0 | GO:0001827 | inner cell mass cell fate commitment(GO:0001827) |
0.3 | 4.0 | GO:0034389 | lipid particle organization(GO:0034389) |
0.3 | 1.0 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
0.3 | 1.0 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.3 | 0.7 | GO:0060486 | Clara cell differentiation(GO:0060486) |
0.3 | 2.0 | GO:0060179 | male mating behavior(GO:0060179) |
0.3 | 0.3 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
0.3 | 0.7 | GO:0034182 | regulation of maintenance of sister chromatid cohesion(GO:0034091) regulation of maintenance of mitotic sister chromatid cohesion(GO:0034182) |
0.3 | 3.6 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.3 | 0.6 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.3 | 0.3 | GO:0061642 | chemoattraction of axon(GO:0061642) |
0.3 | 1.0 | GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
0.3 | 1.6 | GO:1902308 | regulation of peptidyl-serine dephosphorylation(GO:1902308) |
0.3 | 5.1 | GO:0010257 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.3 | 0.3 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
0.3 | 6.3 | GO:0060612 | adipose tissue development(GO:0060612) |
0.3 | 0.9 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.3 | 0.6 | GO:0002540 | leukotriene production involved in inflammatory response(GO:0002540) |
0.3 | 0.9 | GO:0033504 | floor plate development(GO:0033504) |
0.3 | 0.9 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
0.3 | 0.3 | GO:0010897 | negative regulation of triglyceride catabolic process(GO:0010897) |
0.3 | 1.5 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.3 | 6.1 | GO:0021954 | central nervous system neuron development(GO:0021954) |
0.3 | 1.5 | GO:0061042 | vascular wound healing(GO:0061042) |
0.3 | 0.6 | GO:0051489 | regulation of filopodium assembly(GO:0051489) |
0.3 | 0.9 | GO:0070366 | regulation of hepatocyte differentiation(GO:0070366) |
0.3 | 0.3 | GO:1902946 | protein localization to early endosome(GO:1902946) regulation of protein localization to early endosome(GO:1902965) positive regulation of protein localization to early endosome(GO:1902966) |
0.3 | 0.9 | GO:0060060 | post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
0.3 | 1.5 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
0.3 | 4.5 | GO:0035116 | embryonic hindlimb morphogenesis(GO:0035116) |
0.3 | 1.8 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
0.3 | 1.2 | GO:0006086 | acetyl-CoA biosynthetic process from pyruvate(GO:0006086) |
0.3 | 1.5 | GO:1990564 | protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
0.3 | 0.6 | GO:1900425 | negative regulation of defense response to bacterium(GO:1900425) |
0.3 | 0.3 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
0.3 | 2.9 | GO:0002097 | tRNA wobble base modification(GO:0002097) |
0.3 | 0.6 | GO:0061055 | myotome development(GO:0061055) |
0.3 | 1.1 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
0.3 | 0.3 | GO:0070424 | regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070424) regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070432) |
0.3 | 0.6 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
0.3 | 0.8 | GO:0019244 | lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
0.3 | 0.6 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
0.3 | 0.8 | GO:2000381 | negative regulation of mesoderm development(GO:2000381) |
0.3 | 0.8 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.3 | 1.6 | GO:2000727 | positive regulation of cardiac muscle cell differentiation(GO:2000727) |
0.3 | 1.1 | GO:1901026 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
0.3 | 2.1 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.3 | 0.5 | GO:0007354 | zygotic determination of anterior/posterior axis, embryo(GO:0007354) |
0.3 | 1.3 | GO:0048505 | regulation of timing of cell differentiation(GO:0048505) |
0.3 | 1.1 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.3 | 0.5 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
0.3 | 2.4 | GO:0045056 | transcytosis(GO:0045056) |
0.3 | 1.0 | GO:0046477 | glycosylceramide catabolic process(GO:0046477) |
0.3 | 2.4 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.3 | 1.0 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.3 | 1.8 | GO:0021854 | hypothalamus development(GO:0021854) |
0.3 | 0.8 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
0.3 | 0.8 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.3 | 2.0 | GO:0097286 | iron ion import(GO:0097286) |
0.3 | 2.0 | GO:0030575 | nuclear body organization(GO:0030575) |
0.3 | 2.3 | GO:0051573 | negative regulation of histone H3-K9 methylation(GO:0051573) |
0.3 | 1.0 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
0.3 | 0.5 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.3 | 1.3 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.3 | 0.5 | GO:1901033 | positive regulation of response to reactive oxygen species(GO:1901033) |
0.3 | 1.0 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
0.3 | 0.3 | GO:2000409 | positive regulation of T cell extravasation(GO:2000409) |
0.2 | 0.2 | GO:0038089 | positive regulation of cell migration by vascular endothelial growth factor signaling pathway(GO:0038089) |
0.2 | 1.0 | GO:0019530 | taurine metabolic process(GO:0019530) |
0.2 | 1.0 | GO:0051966 | regulation of synaptic transmission, glutamatergic(GO:0051966) |
0.2 | 0.7 | GO:0060988 | lipid tube assembly(GO:0060988) |
0.2 | 0.5 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
0.2 | 1.7 | GO:0006105 | succinate metabolic process(GO:0006105) |
0.2 | 1.9 | GO:0032331 | negative regulation of chondrocyte differentiation(GO:0032331) |
0.2 | 0.7 | GO:0016048 | detection of temperature stimulus(GO:0016048) |
0.2 | 0.7 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.2 | 0.9 | GO:0009256 | 10-formyltetrahydrofolate metabolic process(GO:0009256) |
0.2 | 0.2 | GO:2000275 | regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
0.2 | 0.9 | GO:0001842 | neural fold formation(GO:0001842) |
0.2 | 0.7 | GO:0070272 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.2 | 2.3 | GO:0001964 | startle response(GO:0001964) |
0.2 | 0.2 | GO:0061669 | spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
0.2 | 2.1 | GO:0071435 | potassium ion export(GO:0071435) |
0.2 | 0.5 | GO:0060424 | foregut regionalization(GO:0060423) lung field specification(GO:0060424) lung induction(GO:0060492) |
0.2 | 0.5 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.2 | 0.2 | GO:0035283 | central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
0.2 | 1.6 | GO:1902259 | regulation of delayed rectifier potassium channel activity(GO:1902259) |
0.2 | 0.2 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
0.2 | 0.7 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.2 | 2.1 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.2 | 0.5 | GO:1903421 | regulation of synaptic vesicle recycling(GO:1903421) |
0.2 | 2.3 | GO:0086010 | membrane depolarization during action potential(GO:0086010) |
0.2 | 0.7 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.2 | 3.6 | GO:0060997 | dendritic spine morphogenesis(GO:0060997) |
0.2 | 1.8 | GO:0001755 | neural crest cell migration(GO:0001755) |
0.2 | 0.2 | GO:0072338 | creatinine metabolic process(GO:0046449) cellular lactam metabolic process(GO:0072338) |
0.2 | 1.1 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
0.2 | 0.4 | GO:0060399 | regulation of growth hormone receptor signaling pathway(GO:0060398) positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
0.2 | 0.7 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
0.2 | 2.2 | GO:0006590 | thyroid hormone generation(GO:0006590) |
0.2 | 4.0 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.2 | 1.1 | GO:0050965 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.2 | 0.9 | GO:0009597 | detection of virus(GO:0009597) |
0.2 | 0.4 | GO:0070574 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
0.2 | 0.4 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.2 | 0.9 | GO:1904415 | regulation of xenophagy(GO:1904415) positive regulation of xenophagy(GO:1904417) |
0.2 | 0.2 | GO:0097195 | pilomotor reflex(GO:0097195) |
0.2 | 1.1 | GO:0009146 | purine nucleoside triphosphate catabolic process(GO:0009146) |
0.2 | 0.2 | GO:0090210 | regulation of establishment of blood-brain barrier(GO:0090210) |
0.2 | 0.2 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.2 | 0.4 | GO:0042938 | dipeptide transport(GO:0042938) |
0.2 | 1.0 | GO:0036120 | response to platelet-derived growth factor(GO:0036119) cellular response to platelet-derived growth factor stimulus(GO:0036120) |
0.2 | 0.8 | GO:0019532 | oxalate transport(GO:0019532) |
0.2 | 0.6 | GO:0010046 | response to mycotoxin(GO:0010046) |
0.2 | 0.6 | GO:0033030 | negative regulation of neutrophil apoptotic process(GO:0033030) |
0.2 | 5.7 | GO:0000038 | very long-chain fatty acid metabolic process(GO:0000038) |
0.2 | 0.2 | GO:0071139 | resolution of recombination intermediates(GO:0071139) |
0.2 | 4.2 | GO:0010824 | regulation of centrosome duplication(GO:0010824) |
0.2 | 0.2 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.2 | 0.8 | GO:2001012 | mesenchymal cell differentiation involved in kidney development(GO:0072161) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
0.2 | 0.8 | GO:0070173 | regulation of enamel mineralization(GO:0070173) |
0.2 | 0.6 | GO:0070562 | regulation of vitamin D receptor signaling pathway(GO:0070562) |
0.2 | 0.4 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
0.2 | 0.2 | GO:1901380 | negative regulation of potassium ion transmembrane transport(GO:1901380) |
0.2 | 0.2 | GO:0002017 | regulation of blood volume by renal aldosterone(GO:0002017) |
0.2 | 1.5 | GO:0014741 | negative regulation of muscle hypertrophy(GO:0014741) |
0.2 | 2.1 | GO:0048745 | smooth muscle tissue development(GO:0048745) |
0.2 | 1.3 | GO:0042407 | cristae formation(GO:0042407) |
0.2 | 0.2 | GO:1904016 | response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
0.2 | 0.2 | GO:0010751 | negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
0.2 | 0.2 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
0.2 | 0.2 | GO:2000437 | monocyte extravasation(GO:0035696) regulation of monocyte extravasation(GO:2000437) |
0.2 | 0.4 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.2 | 0.6 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.2 | 0.6 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
0.2 | 0.6 | GO:0003157 | endocardium development(GO:0003157) |
0.2 | 1.1 | GO:0051968 | positive regulation of synaptic transmission, glutamatergic(GO:0051968) |
0.2 | 0.4 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.2 | 0.5 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
0.2 | 0.5 | GO:0046543 | development of secondary female sexual characteristics(GO:0046543) |
0.2 | 0.7 | GO:0010452 | histone H3-K36 methylation(GO:0010452) |
0.2 | 0.4 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
0.2 | 0.5 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
0.2 | 0.5 | GO:0051103 | DNA ligation involved in DNA repair(GO:0051103) |
0.2 | 0.5 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
0.2 | 0.2 | GO:0010159 | specification of organ position(GO:0010159) |
0.2 | 0.4 | GO:0019086 | late viral transcription(GO:0019086) |
0.2 | 0.5 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
0.2 | 0.7 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
0.2 | 1.4 | GO:1901407 | regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.2 | 1.2 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
0.2 | 3.1 | GO:0042537 | benzene-containing compound metabolic process(GO:0042537) |
0.2 | 1.0 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
0.2 | 0.3 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) |
0.2 | 0.2 | GO:0001698 | gastrin-induced gastric acid secretion(GO:0001698) |
0.2 | 0.2 | GO:0006533 | aspartate catabolic process(GO:0006533) |
0.2 | 0.5 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.2 | 1.5 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
0.2 | 0.2 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.2 | 0.5 | GO:0017198 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.2 | 0.5 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
0.2 | 0.3 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
0.2 | 0.2 | GO:0060750 | epithelial cell proliferation involved in mammary gland duct elongation(GO:0060750) |
0.2 | 1.1 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.2 | 0.8 | GO:0042428 | serotonin metabolic process(GO:0042428) |
0.2 | 0.5 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.2 | 0.8 | GO:0090042 | tubulin deacetylation(GO:0090042) regulation of tubulin deacetylation(GO:0090043) |
0.2 | 0.8 | GO:0042754 | negative regulation of circadian rhythm(GO:0042754) |
0.2 | 5.5 | GO:0001541 | ovarian follicle development(GO:0001541) |
0.2 | 3.4 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.2 | 0.3 | GO:0035701 | hematopoietic stem cell migration(GO:0035701) |
0.2 | 2.1 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.2 | 0.2 | GO:0071569 | protein ufmylation(GO:0071569) |
0.2 | 3.5 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
0.2 | 0.3 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.2 | 0.2 | GO:0009996 | negative regulation of cell fate specification(GO:0009996) |
0.2 | 0.2 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
0.2 | 0.2 | GO:0006848 | pyruvate transport(GO:0006848) pyruvate transmembrane transport(GO:1901475) |
0.2 | 0.3 | GO:1901857 | positive regulation of cellular respiration(GO:1901857) |
0.2 | 0.3 | GO:0002370 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
0.2 | 0.3 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
0.2 | 0.9 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.2 | 0.2 | GO:0034756 | regulation of iron ion transport(GO:0034756) |
0.2 | 3.0 | GO:0006379 | mRNA cleavage(GO:0006379) |
0.2 | 0.3 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
0.1 | 0.1 | GO:0030497 | fatty acid elongation(GO:0030497) |
0.1 | 0.6 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.1 | 1.8 | GO:0032968 | positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
0.1 | 0.6 | GO:0046654 | tetrahydrofolate biosynthetic process(GO:0046654) |
0.1 | 0.4 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
0.1 | 0.4 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
0.1 | 0.3 | GO:0021895 | cerebral cortex neuron differentiation(GO:0021895) |
0.1 | 0.4 | GO:0072530 | purine nucleoside transmembrane transport(GO:0015860) purine-containing compound transmembrane transport(GO:0072530) nucleoside transmembrane transport(GO:1901642) |
0.1 | 0.7 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.1 | 0.4 | GO:0032049 | cardiolipin biosynthetic process(GO:0032049) |
0.1 | 0.6 | GO:0030091 | protein repair(GO:0030091) |
0.1 | 1.6 | GO:0006968 | cellular defense response(GO:0006968) |
0.1 | 0.6 | GO:0006824 | cobalt ion transport(GO:0006824) |
0.1 | 0.3 | GO:0003348 | cardiac endothelial cell differentiation(GO:0003348) |
0.1 | 0.4 | GO:0002282 | microglial cell activation involved in immune response(GO:0002282) |
0.1 | 1.4 | GO:0003323 | type B pancreatic cell development(GO:0003323) |
0.1 | 0.8 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.1 | 0.3 | GO:0035878 | nail development(GO:0035878) |
0.1 | 0.4 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
0.1 | 1.1 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.1 | 2.9 | GO:0046677 | response to antibiotic(GO:0046677) |
0.1 | 1.1 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.1 | 0.4 | GO:0035188 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.1 | 0.1 | GO:0003032 | detection of oxygen(GO:0003032) |
0.1 | 0.3 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.1 | 0.4 | GO:2000254 | regulation of male germ cell proliferation(GO:2000254) |
0.1 | 0.8 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.1 | 0.5 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.1 | 0.3 | GO:2000224 | regulation of testosterone biosynthetic process(GO:2000224) |
0.1 | 0.1 | GO:0042424 | catechol-containing compound catabolic process(GO:0019614) catecholamine catabolic process(GO:0042424) |
0.1 | 0.1 | GO:0010520 | regulation of reciprocal meiotic recombination(GO:0010520) |
0.1 | 10.3 | GO:0006836 | neurotransmitter transport(GO:0006836) |
0.1 | 0.3 | GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
0.1 | 0.8 | GO:0007343 | egg activation(GO:0007343) |
0.1 | 0.4 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.1 | 2.8 | GO:0008542 | visual learning(GO:0008542) |
0.1 | 0.5 | GO:0033578 | protein glycosylation in Golgi(GO:0033578) |
0.1 | 0.3 | GO:0010909 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
0.1 | 0.1 | GO:0060298 | positive regulation of sarcomere organization(GO:0060298) |
0.1 | 0.4 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.1 | 0.8 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.1 | 1.9 | GO:0061178 | regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061178) |
0.1 | 0.2 | GO:2001201 | transforming growth factor-beta secretion(GO:0038044) regulation of transforming growth factor-beta secretion(GO:2001201) |
0.1 | 1.1 | GO:0051532 | regulation of NFAT protein import into nucleus(GO:0051532) |
0.1 | 0.5 | GO:0006551 | leucine metabolic process(GO:0006551) |
0.1 | 0.2 | GO:0051571 | positive regulation of histone H3-K4 methylation(GO:0051571) |
0.1 | 0.1 | GO:1904995 | negative regulation of leukocyte adhesion to vascular endothelial cell(GO:1904995) |
0.1 | 1.6 | GO:0048025 | negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
0.1 | 0.1 | GO:1900227 | positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
0.1 | 0.4 | GO:0046668 | regulation of retinal cell programmed cell death(GO:0046668) |
0.1 | 0.1 | GO:0072298 | regulation of metanephric glomerulus development(GO:0072298) positive regulation of metanephric glomerulus development(GO:0072300) |
0.1 | 0.5 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.1 | 0.2 | GO:0032687 | negative regulation of interferon-alpha production(GO:0032687) |
0.1 | 0.6 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.1 | 0.6 | GO:0018101 | protein citrullination(GO:0018101) |
0.1 | 0.5 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
0.1 | 0.1 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
0.1 | 0.3 | GO:0019464 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.1 | 0.1 | GO:0002093 | auditory receptor cell morphogenesis(GO:0002093) |
0.1 | 0.3 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
0.1 | 0.1 | GO:0010725 | regulation of primitive erythrocyte differentiation(GO:0010725) |
0.1 | 0.1 | GO:0072393 | microtubule anchoring at microtubule organizing center(GO:0072393) |
0.1 | 1.2 | GO:1904293 | negative regulation of ERAD pathway(GO:1904293) |
0.1 | 0.4 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.1 | 0.8 | GO:1904355 | positive regulation of telomere capping(GO:1904355) |
0.1 | 1.9 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.1 | 0.7 | GO:0006265 | DNA topological change(GO:0006265) |
0.1 | 0.2 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.1 | 0.3 | GO:0035249 | synaptic transmission, glutamatergic(GO:0035249) |
0.1 | 0.4 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.1 | 0.4 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.1 | 0.2 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.1 | 0.2 | GO:0006041 | glucosamine metabolic process(GO:0006041) |
0.1 | 0.6 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.1 | 0.3 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.1 | 0.2 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.1 | 0.4 | GO:0032827 | natural killer cell differentiation involved in immune response(GO:0002325) negative regulation of natural killer cell differentiation(GO:0032824) regulation of natural killer cell differentiation involved in immune response(GO:0032826) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) |
0.1 | 0.1 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.1 | 0.8 | GO:0000459 | exonucleolytic trimming involved in rRNA processing(GO:0000459) exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000467) |
0.1 | 0.2 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.1 | 1.0 | GO:0034315 | regulation of Arp2/3 complex-mediated actin nucleation(GO:0034315) |
0.1 | 0.3 | GO:0008054 | negative regulation of cyclin-dependent protein serine/threonine kinase by cyclin degradation(GO:0008054) |
0.1 | 0.5 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
0.1 | 0.4 | GO:0007320 | insemination(GO:0007320) |
0.1 | 0.3 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
0.1 | 0.1 | GO:0016078 | tRNA catabolic process(GO:0016078) |
0.1 | 0.1 | GO:0060982 | coronary artery morphogenesis(GO:0060982) |
0.1 | 0.6 | GO:0051324 | meiotic prophase I(GO:0007128) prophase(GO:0051324) meiotic cell cycle phase(GO:0098762) meiosis I cell cycle phase(GO:0098764) |
0.1 | 0.1 | GO:0050974 | detection of mechanical stimulus involved in sensory perception(GO:0050974) |
0.1 | 0.4 | GO:0090085 | regulation of protein deubiquitination(GO:0090085) |
0.1 | 0.3 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
0.1 | 0.1 | GO:1903011 | negative regulation of bone development(GO:1903011) |
0.1 | 0.1 | GO:0000429 | carbon catabolite regulation of transcription from RNA polymerase II promoter(GO:0000429) regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) carbon catabolite activation of transcription from RNA polymerase II promoter(GO:0000436) |
0.1 | 0.7 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.1 | 0.1 | GO:2000111 | positive regulation of macrophage apoptotic process(GO:2000111) |
0.1 | 1.9 | GO:0019835 | cytolysis(GO:0019835) |
0.1 | 0.1 | GO:0090148 | membrane fission(GO:0090148) |
0.1 | 0.5 | GO:0000052 | citrulline metabolic process(GO:0000052) |
0.1 | 0.4 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
0.1 | 2.5 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.1 | 0.4 | GO:0072378 | blood coagulation, fibrin clot formation(GO:0072378) |
0.1 | 0.3 | GO:0015822 | ornithine transport(GO:0015822) L-ornithine transmembrane transport(GO:1903352) |
0.1 | 2.3 | GO:0045104 | intermediate filament cytoskeleton organization(GO:0045104) |
0.1 | 0.3 | GO:0070601 | centromeric sister chromatid cohesion(GO:0070601) |
0.1 | 0.4 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
0.1 | 0.3 | GO:0032308 | positive regulation of prostaglandin secretion(GO:0032308) |
0.1 | 0.2 | GO:0014717 | regulation of satellite cell activation involved in skeletal muscle regeneration(GO:0014717) satellite cell activation involved in skeletal muscle regeneration(GO:0014901) |
0.1 | 0.2 | GO:0070365 | hepatocyte differentiation(GO:0070365) |
0.1 | 0.2 | GO:0032430 | positive regulation of phospholipase A2 activity(GO:0032430) |
0.1 | 0.1 | GO:0002538 | arachidonic acid metabolite production involved in inflammatory response(GO:0002538) |
0.1 | 0.4 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.1 | 0.9 | GO:2001015 | negative regulation of skeletal muscle cell differentiation(GO:2001015) |
0.1 | 0.1 | GO:0031627 | telomeric loop formation(GO:0031627) |
0.1 | 0.3 | GO:1900037 | regulation of cellular response to hypoxia(GO:1900037) |
0.1 | 0.1 | GO:0009436 | glyoxylate catabolic process(GO:0009436) |
0.1 | 0.1 | GO:2000698 | positive regulation of epithelial cell differentiation involved in kidney development(GO:2000698) |
0.1 | 0.6 | GO:0034063 | stress granule assembly(GO:0034063) |
0.1 | 0.3 | GO:0016322 | neuron remodeling(GO:0016322) |
0.1 | 0.3 | GO:0043928 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
0.1 | 0.2 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
0.1 | 0.2 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
0.1 | 0.2 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
0.1 | 0.2 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.1 | 0.3 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.1 | 0.1 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.1 | 0.1 | GO:0043084 | penile erection(GO:0043084) |
0.1 | 0.2 | GO:0070295 | renal water absorption(GO:0070295) |
0.1 | 0.1 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.1 | 1.1 | GO:0048240 | sperm capacitation(GO:0048240) |
0.1 | 0.1 | GO:1901535 | regulation of DNA demethylation(GO:1901535) negative regulation of DNA demethylation(GO:1901536) |
0.1 | 0.3 | GO:0045410 | positive regulation of interleukin-6 biosynthetic process(GO:0045410) |
0.1 | 0.1 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
0.1 | 0.5 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
0.1 | 0.1 | GO:0015755 | fructose transport(GO:0015755) |
0.1 | 0.4 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.1 | 0.3 | GO:0051189 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.1 | 0.5 | GO:0051797 | regulation of hair follicle development(GO:0051797) |
0.1 | 0.1 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.1 | 0.3 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
0.1 | 0.1 | GO:0071694 | sequestering of BMP in extracellular matrix(GO:0035582) protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
0.1 | 0.4 | GO:0090266 | regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) regulation of mitotic spindle checkpoint(GO:1903504) |
0.1 | 0.1 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
0.1 | 0.1 | GO:0045724 | positive regulation of cilium assembly(GO:0045724) |
0.1 | 0.4 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.1 | 0.6 | GO:0036065 | fucosylation(GO:0036065) |
0.1 | 0.4 | GO:0060999 | positive regulation of dendritic spine development(GO:0060999) |
0.1 | 0.3 | GO:0035584 | calcium-mediated signaling using intracellular calcium source(GO:0035584) |
0.1 | 0.3 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
0.1 | 1.0 | GO:0045022 | early endosome to late endosome transport(GO:0045022) |
0.1 | 0.1 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
0.1 | 0.4 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.1 | 0.3 | GO:0045579 | positive regulation of B cell differentiation(GO:0045579) |
0.1 | 0.1 | GO:0046984 | regulation of hemoglobin biosynthetic process(GO:0046984) |
0.1 | 0.2 | GO:0009139 | dUDP biosynthetic process(GO:0006227) pyrimidine nucleoside diphosphate biosynthetic process(GO:0009139) pyrimidine deoxyribonucleoside diphosphate metabolic process(GO:0009196) pyrimidine deoxyribonucleoside diphosphate biosynthetic process(GO:0009197) dUDP metabolic process(GO:0046077) |
0.1 | 0.2 | GO:0048619 | embryonic hindgut morphogenesis(GO:0048619) |
0.1 | 0.1 | GO:0000255 | allantoin metabolic process(GO:0000255) |
0.1 | 0.1 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.1 | 0.1 | GO:0060856 | establishment of blood-brain barrier(GO:0060856) |
0.1 | 0.1 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
0.1 | 0.1 | GO:0070268 | cornification(GO:0070268) |
0.1 | 0.1 | GO:0035166 | post-embryonic hemopoiesis(GO:0035166) |
0.1 | 0.2 | GO:0070535 | histone H2A K63-linked ubiquitination(GO:0070535) |
0.1 | 0.5 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.1 | 0.7 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.1 | 0.2 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.1 | 0.7 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.1 | 0.1 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.1 | 0.7 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.1 | 0.1 | GO:2000619 | negative regulation of histone H4-K16 acetylation(GO:2000619) |
0.1 | 0.1 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
0.1 | 0.5 | GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
0.1 | 0.1 | GO:0048254 | snoRNA localization(GO:0048254) |
0.1 | 0.2 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
0.1 | 0.1 | GO:0071428 | rRNA export from nucleus(GO:0006407) rRNA-containing ribonucleoprotein complex export from nucleus(GO:0071428) |
0.1 | 1.6 | GO:0098840 | protein transport along microtubule(GO:0098840) |
0.1 | 0.9 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.1 | 0.1 | GO:0042494 | detection of bacterial lipoprotein(GO:0042494) |
0.1 | 0.1 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
0.1 | 0.6 | GO:0046621 | negative regulation of organ growth(GO:0046621) |
0.1 | 0.2 | GO:0060539 | diaphragm development(GO:0060539) |
0.1 | 0.2 | GO:0019627 | urea cycle(GO:0000050) urea metabolic process(GO:0019627) |
0.1 | 3.8 | GO:0008033 | tRNA processing(GO:0008033) |
0.1 | 0.2 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
0.1 | 0.2 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
0.1 | 0.1 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.1 | 0.1 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) |
0.1 | 0.1 | GO:0003257 | positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation(GO:0003257) |
0.1 | 0.3 | GO:0015074 | DNA integration(GO:0015074) |
0.1 | 1.6 | GO:0098661 | inorganic anion transmembrane transport(GO:0098661) |
0.1 | 0.1 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
0.1 | 0.2 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
0.1 | 0.1 | GO:0001905 | activation of membrane attack complex(GO:0001905) regulation of activation of membrane attack complex(GO:0001969) |
0.1 | 0.1 | GO:0010912 | regulation of isomerase activity(GO:0010911) positive regulation of isomerase activity(GO:0010912) |
0.1 | 0.3 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.0 | 0.1 | GO:0000270 | peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) |
0.0 | 0.2 | GO:0018317 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.0 | 0.1 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
0.0 | 2.0 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.0 | 0.0 | GO:0061010 | gall bladder development(GO:0061010) |
0.0 | 0.1 | GO:0035898 | parathyroid hormone secretion(GO:0035898) |
0.0 | 0.1 | GO:0032471 | negative regulation of endoplasmic reticulum calcium ion concentration(GO:0032471) |
0.0 | 0.6 | GO:0042104 | positive regulation of activated T cell proliferation(GO:0042104) |
0.0 | 0.2 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
0.0 | 0.2 | GO:0051503 | adenine nucleotide transport(GO:0051503) |
0.0 | 0.3 | GO:0046847 | filopodium assembly(GO:0046847) |
0.0 | 0.0 | GO:0022605 | oogenesis stage(GO:0022605) |
0.0 | 0.0 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.0 | 0.0 | GO:1902093 | positive regulation of sperm motility(GO:1902093) |
0.0 | 0.1 | GO:1901509 | regulation of endothelial tube morphogenesis(GO:1901509) |
0.0 | 0.1 | GO:0002689 | negative regulation of leukocyte chemotaxis(GO:0002689) |
0.0 | 0.0 | GO:0018158 | protein oxidation(GO:0018158) |
0.0 | 0.0 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
0.0 | 0.1 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.0 | 0.2 | GO:0033523 | histone H2B ubiquitination(GO:0033523) |
0.0 | 0.0 | GO:0003310 | pancreatic A cell differentiation(GO:0003310) |
0.0 | 0.3 | GO:0034643 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
0.0 | 0.1 | GO:0034441 | plasma lipoprotein particle oxidation(GO:0034441) |
0.0 | 0.1 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
0.0 | 0.1 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.0 | 0.0 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
0.0 | 0.0 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
0.0 | 0.1 | GO:0048550 | negative regulation of pinocytosis(GO:0048550) |
0.0 | 0.0 | GO:0021764 | amygdala development(GO:0021764) |
0.0 | 0.1 | GO:0071941 | nitrogen cycle metabolic process(GO:0071941) |
0.0 | 0.0 | GO:0051025 | negative regulation of immunoglobulin secretion(GO:0051025) |
0.0 | 0.0 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
0.0 | 0.2 | GO:0043576 | regulation of respiratory gaseous exchange(GO:0043576) |
0.0 | 0.1 | GO:1903232 | melanosome assembly(GO:1903232) |
0.0 | 0.0 | GO:1902956 | regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902956) |
0.0 | 0.2 | GO:0071554 | cell wall macromolecule metabolic process(GO:0044036) cell wall organization or biogenesis(GO:0071554) |
0.0 | 0.2 | GO:0042790 | transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:0042790) |
0.0 | 0.1 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
0.0 | 1.2 | GO:0070098 | chemokine-mediated signaling pathway(GO:0070098) |
0.0 | 0.3 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.0 | 0.1 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
0.0 | 2.6 | GO:0007605 | sensory perception of sound(GO:0007605) |
0.0 | 0.1 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
0.0 | 0.1 | GO:0006393 | termination of mitochondrial transcription(GO:0006393) |
0.0 | 0.0 | GO:0010956 | negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) |
0.0 | 0.5 | GO:0007271 | synaptic transmission, cholinergic(GO:0007271) |
0.0 | 0.4 | GO:0008209 | androgen metabolic process(GO:0008209) |
0.0 | 0.1 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
0.0 | 0.3 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
0.0 | 0.1 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
0.0 | 0.0 | GO:2000252 | negative regulation of feeding behavior(GO:2000252) |
0.0 | 0.1 | GO:0010901 | regulation of very-low-density lipoprotein particle remodeling(GO:0010901) |
0.0 | 0.0 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
0.0 | 0.1 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
0.0 | 0.1 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.0 | 0.2 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
0.0 | 0.2 | GO:0036465 | synaptic vesicle recycling(GO:0036465) |
0.0 | 0.0 | GO:0048841 | regulation of axon extension involved in axon guidance(GO:0048841) |
0.0 | 0.1 | GO:0014721 | voluntary skeletal muscle contraction(GO:0003010) twitch skeletal muscle contraction(GO:0014721) |
0.0 | 0.1 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.0 | 0.3 | GO:0071242 | cellular response to ammonium ion(GO:0071242) |
0.0 | 0.1 | GO:0030202 | heparin metabolic process(GO:0030202) |
0.0 | 0.0 | GO:0072008 | glomerular mesangial cell differentiation(GO:0072008) glomerular mesangial cell development(GO:0072144) |
0.0 | 0.0 | GO:0046959 | nonassociative learning(GO:0046958) habituation(GO:0046959) |
0.0 | 0.0 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
0.0 | 0.0 | GO:0006573 | valine metabolic process(GO:0006573) |
0.0 | 0.0 | GO:0050951 | sensory perception of temperature stimulus(GO:0050951) |
0.0 | 0.0 | GO:0021699 | cerebellar cortex maturation(GO:0021699) |
0.0 | 0.2 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
0.0 | 0.0 | GO:0045852 | pH elevation(GO:0045852) intracellular pH elevation(GO:0051454) |
0.0 | 0.2 | GO:0006273 | lagging strand elongation(GO:0006273) |
0.0 | 0.0 | GO:0033091 | positive regulation of immature T cell proliferation(GO:0033091) |
0.0 | 0.1 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
0.0 | 0.0 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.0 | 0.0 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
0.0 | 0.1 | GO:1904469 | positive regulation of tumor necrosis factor secretion(GO:1904469) |
0.0 | 0.1 | GO:0046116 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.0 | 0.3 | GO:0006378 | mRNA polyadenylation(GO:0006378) RNA polyadenylation(GO:0043631) |
0.0 | 0.1 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
0.0 | 0.1 | GO:0090308 | regulation of methylation-dependent chromatin silencing(GO:0090308) |
0.0 | 0.0 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
0.0 | 0.0 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.0 | 0.1 | GO:0072520 | seminiferous tubule development(GO:0072520) |
0.0 | 0.1 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
0.0 | 0.1 | GO:0010025 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.0 | 0.4 | GO:0045739 | positive regulation of DNA repair(GO:0045739) |
0.0 | 0.1 | GO:0001787 | natural killer cell proliferation(GO:0001787) |
0.0 | 0.0 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
0.0 | 0.2 | GO:0033753 | ribosomal subunit export from nucleus(GO:0000054) ribosome localization(GO:0033750) establishment of ribosome localization(GO:0033753) |
0.0 | 1.8 | GO:0006813 | potassium ion transport(GO:0006813) |
0.0 | 0.0 | GO:0015889 | cobalamin transport(GO:0015889) |
0.0 | 0.0 | GO:0071732 | cellular response to nitric oxide(GO:0071732) |
0.0 | 0.0 | GO:0061081 | positive regulation of myeloid leukocyte cytokine production involved in immune response(GO:0061081) |
0.0 | 0.1 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
0.0 | 0.4 | GO:0050771 | negative regulation of axonogenesis(GO:0050771) |
0.0 | 0.0 | GO:1903207 | neuron death in response to hydrogen peroxide(GO:0036476) regulation of hydrogen peroxide-induced neuron death(GO:1903207) negative regulation of hydrogen peroxide-induced neuron death(GO:1903208) |
0.0 | 0.0 | GO:0061309 | cardiac neural crest cell development involved in outflow tract morphogenesis(GO:0061309) |
0.0 | 0.0 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.0 | 0.1 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.0 | 0.1 | GO:0072502 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.0 | 0.0 | GO:0000098 | sulfur amino acid catabolic process(GO:0000098) |
0.0 | 0.1 | GO:0000491 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.0 | 0.0 | GO:0032058 | positive regulation of translational initiation in response to stress(GO:0032058) |
0.0 | 0.0 | GO:0042074 | cell migration involved in gastrulation(GO:0042074) |
0.0 | 0.0 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
0.0 | 0.1 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.0 | 0.0 | GO:0014072 | response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
0.0 | 0.0 | GO:1901740 | negative regulation of myoblast fusion(GO:1901740) |
0.0 | 0.0 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) |
0.0 | 0.1 | GO:0006547 | histidine metabolic process(GO:0006547) |
0.0 | 0.3 | GO:1901264 | carbohydrate derivative transport(GO:1901264) |
0.0 | 0.0 | GO:0097212 | lysosomal membrane organization(GO:0097212) |
0.0 | 0.1 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
0.0 | 0.0 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
0.0 | 0.0 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.0 | 0.0 | GO:0051654 | establishment of mitochondrion localization(GO:0051654) |
0.0 | 0.0 | GO:0034214 | protein hexamerization(GO:0034214) |
0.0 | 0.0 | GO:0022615 | protein to membrane docking(GO:0022615) |
0.0 | 0.0 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
0.0 | 0.0 | GO:2000327 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
0.0 | 0.0 | GO:0071321 | cellular response to cGMP(GO:0071321) |
0.0 | 0.0 | GO:0033600 | negative regulation of mammary gland epithelial cell proliferation(GO:0033600) |
0.0 | 0.0 | GO:0032026 | response to magnesium ion(GO:0032026) |
0.0 | 0.1 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
0.0 | 0.0 | GO:0021819 | layer formation in cerebral cortex(GO:0021819) |
0.0 | 0.0 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.0 | 0.0 | GO:0042402 | amine catabolic process(GO:0009310) cellular biogenic amine catabolic process(GO:0042402) |
0.0 | 0.0 | GO:0014029 | neural crest formation(GO:0014029) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.0 | 19.8 | GO:0033269 | internode region of axon(GO:0033269) |
4.5 | 13.5 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
3.3 | 10.0 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
3.3 | 13.2 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
3.3 | 16.3 | GO:0000235 | astral microtubule(GO:0000235) |
2.3 | 6.9 | GO:1990812 | growth cone filopodium(GO:1990812) |
2.2 | 22.1 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
2.0 | 10.1 | GO:0097433 | dense body(GO:0097433) |
2.0 | 17.9 | GO:0035253 | ciliary rootlet(GO:0035253) |
1.8 | 7.1 | GO:1990696 | USH2 complex(GO:1990696) |
1.7 | 6.7 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
1.6 | 26.8 | GO:0030673 | axolemma(GO:0030673) |
1.5 | 18.1 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
1.4 | 11.1 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
1.3 | 4.0 | GO:0005879 | axonemal microtubule(GO:0005879) |
1.3 | 9.4 | GO:0098563 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
1.3 | 32.5 | GO:0044295 | axonal growth cone(GO:0044295) |
1.3 | 10.0 | GO:0034464 | BBSome(GO:0034464) |
1.1 | 2.1 | GO:0035748 | myelin sheath abaxonal region(GO:0035748) |
1.0 | 2.0 | GO:0038037 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
1.0 | 3.8 | GO:0045293 | mRNA editing complex(GO:0045293) |
0.9 | 0.9 | GO:0071437 | invadopodium(GO:0071437) |
0.9 | 9.8 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.9 | 1.7 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.9 | 9.5 | GO:0043194 | axon initial segment(GO:0043194) |
0.9 | 3.4 | GO:0043159 | acrosomal matrix(GO:0043159) |
0.8 | 3.3 | GO:0030478 | actin cap(GO:0030478) |
0.8 | 13.2 | GO:0097440 | apical dendrite(GO:0097440) |
0.8 | 4.1 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
0.8 | 1.6 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.8 | 4.1 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.8 | 3.9 | GO:0005579 | membrane attack complex(GO:0005579) |
0.8 | 3.0 | GO:0061574 | ASAP complex(GO:0061574) |
0.7 | 4.4 | GO:0043083 | synaptic cleft(GO:0043083) |
0.7 | 10.2 | GO:0031045 | dense core granule(GO:0031045) |
0.7 | 5.1 | GO:0030681 | nucleolar ribonuclease P complex(GO:0005655) ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
0.7 | 2.1 | GO:1990131 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.7 | 11.4 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.7 | 26.7 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.7 | 3.4 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.7 | 2.0 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.7 | 2.7 | GO:1990130 | Iml1 complex(GO:1990130) |
0.7 | 18.5 | GO:0098878 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
0.7 | 2.0 | GO:0055087 | Ski complex(GO:0055087) |
0.6 | 2.5 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.6 | 2.4 | GO:0016942 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.6 | 1.7 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.6 | 31.3 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.6 | 2.8 | GO:0071547 | piP-body(GO:0071547) |
0.5 | 4.8 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.5 | 1.6 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.5 | 2.1 | GO:0035339 | SPOTS complex(GO:0035339) |
0.5 | 1.5 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.5 | 2.0 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.5 | 1.5 | GO:0097427 | microtubule bundle(GO:0097427) |
0.5 | 74.6 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.5 | 0.9 | GO:0072534 | perineuronal net(GO:0072534) |
0.5 | 1.4 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
0.5 | 2.8 | GO:0016011 | dystroglycan complex(GO:0016011) sarcoglycan complex(GO:0016012) |
0.5 | 4.6 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.4 | 1.8 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.4 | 1.3 | GO:0043511 | inhibin complex(GO:0043511) |
0.4 | 1.8 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.4 | 0.9 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.4 | 0.8 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.4 | 6.9 | GO:0044298 | cell body membrane(GO:0044298) |
0.4 | 2.0 | GO:0061617 | MICOS complex(GO:0061617) |
0.4 | 4.8 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.4 | 15.6 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
0.4 | 2.7 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.4 | 0.8 | GO:0032280 | symmetric synapse(GO:0032280) |
0.4 | 0.4 | GO:0016939 | kinesin II complex(GO:0016939) |
0.4 | 3.6 | GO:0032433 | filopodium tip(GO:0032433) |
0.4 | 1.1 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.3 | 38.1 | GO:0070382 | exocytic vesicle(GO:0070382) |
0.3 | 1.4 | GO:0051286 | cell tip(GO:0051286) |
0.3 | 3.7 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.3 | 5.1 | GO:0070822 | Sin3-type complex(GO:0070822) |
0.3 | 3.0 | GO:0005766 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.3 | 4.6 | GO:0043205 | fibril(GO:0043205) |
0.3 | 2.3 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.3 | 2.9 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.3 | 3.2 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.3 | 3.2 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.3 | 0.9 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.3 | 2.8 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.3 | 3.3 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.3 | 0.9 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.3 | 3.6 | GO:0031527 | filopodium membrane(GO:0031527) |
0.3 | 1.7 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.3 | 1.2 | GO:0071817 | MMXD complex(GO:0071817) |
0.3 | 2.3 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.3 | 3.1 | GO:0035102 | PRC1 complex(GO:0035102) |
0.3 | 0.8 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
0.3 | 0.8 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
0.3 | 0.8 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.3 | 0.8 | GO:0005608 | laminin-3 complex(GO:0005608) |
0.3 | 9.1 | GO:0030175 | filopodium(GO:0030175) |
0.3 | 1.3 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.3 | 4.2 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.3 | 0.8 | GO:0048179 | activin receptor complex(GO:0048179) |
0.3 | 1.0 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.3 | 3.6 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) |
0.3 | 4.1 | GO:0016581 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
0.3 | 1.0 | GO:0000125 | PCAF complex(GO:0000125) |
0.2 | 6.5 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.2 | 1.5 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.2 | 1.0 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.2 | 0.7 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.2 | 1.1 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.2 | 1.3 | GO:0070852 | cell body fiber(GO:0070852) |
0.2 | 11.6 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.2 | 1.0 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.2 | 10.0 | GO:0043204 | perikaryon(GO:0043204) |
0.2 | 52.1 | GO:0030424 | axon(GO:0030424) |
0.2 | 2.4 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.2 | 0.4 | GO:0000322 | storage vacuole(GO:0000322) |
0.2 | 1.3 | GO:0005686 | U2 snRNP(GO:0005686) |
0.2 | 0.7 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
0.2 | 1.5 | GO:0031528 | microvillus membrane(GO:0031528) |
0.2 | 0.8 | GO:0044306 | neuron projection terminus(GO:0044306) |
0.2 | 0.6 | GO:0032389 | MutLalpha complex(GO:0032389) |
0.2 | 1.1 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.2 | 4.3 | GO:0005763 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.2 | 5.7 | GO:0005871 | kinesin complex(GO:0005871) |
0.2 | 4.2 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.2 | 0.5 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.2 | 2.0 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.2 | 0.2 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
0.1 | 1.0 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.1 | 2.1 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.1 | 2.3 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.1 | 1.3 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.1 | 0.4 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.1 | 1.1 | GO:0016600 | flotillin complex(GO:0016600) |
0.1 | 1.3 | GO:0000778 | condensed nuclear chromosome kinetochore(GO:0000778) |
0.1 | 2.4 | GO:0005685 | U1 snRNP(GO:0005685) |
0.1 | 0.4 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.1 | 2.3 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.1 | 0.7 | GO:0005796 | Golgi lumen(GO:0005796) |
0.1 | 0.1 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.1 | 0.5 | GO:0033503 | HULC complex(GO:0033503) |
0.1 | 0.4 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.1 | 0.2 | GO:0045263 | proton-transporting ATP synthase complex, coupling factor F(o)(GO:0045263) |
0.1 | 4.3 | GO:0000315 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.1 | 0.7 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.1 | 0.9 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.1 | 0.3 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.1 | 0.3 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.1 | 0.7 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.1 | 0.2 | GO:0033010 | paranodal junction(GO:0033010) |
0.1 | 0.2 | GO:0005687 | U4 snRNP(GO:0005687) |
0.1 | 0.1 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.1 | 9.4 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.1 | 0.4 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.1 | 2.3 | GO:0097610 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.1 | 0.1 | GO:0044393 | microspike(GO:0044393) |
0.1 | 0.2 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.1 | 0.4 | GO:1990246 | uniplex complex(GO:1990246) |
0.1 | 0.6 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.1 | 1.6 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.1 | 0.6 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.1 | 0.8 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.1 | 0.4 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.1 | 0.5 | GO:0002177 | manchette(GO:0002177) |
0.1 | 0.5 | GO:0019814 | immunoglobulin complex(GO:0019814) |
0.1 | 0.3 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.1 | 0.3 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.1 | 0.2 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.1 | 0.5 | GO:0001520 | outer dense fiber(GO:0001520) |
0.1 | 0.6 | GO:0097225 | sperm midpiece(GO:0097225) |
0.1 | 0.4 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.1 | 1.2 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.1 | 0.2 | GO:0030897 | HOPS complex(GO:0030897) |
0.1 | 0.4 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.1 | 0.2 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
0.1 | 1.8 | GO:0034704 | calcium channel complex(GO:0034704) |
0.0 | 2.0 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.0 | 0.2 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.0 | 0.0 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.0 | 0.2 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.0 | 0.0 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
0.0 | 0.2 | GO:0098642 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
0.0 | 0.1 | GO:0033263 | CORVET complex(GO:0033263) |
0.0 | 0.2 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.0 | 0.2 | GO:0031502 | dolichyl-phosphate-mannose-protein mannosyltransferase complex(GO:0031502) |
0.0 | 0.0 | GO:0045277 | respiratory chain complex IV(GO:0045277) |
0.0 | 0.3 | GO:0042627 | chylomicron(GO:0042627) |
0.0 | 2.6 | GO:0070160 | occluding junction(GO:0070160) |
0.0 | 0.3 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.0 | 0.4 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
0.0 | 0.0 | GO:0070695 | FHF complex(GO:0070695) |
0.0 | 1.7 | GO:0005746 | mitochondrial respiratory chain(GO:0005746) |
0.0 | 0.4 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.0 | 0.2 | GO:0030008 | TRAPP complex(GO:0030008) |
0.0 | 0.1 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.0 | 0.1 | GO:0045298 | tubulin complex(GO:0045298) |
0.0 | 0.2 | GO:0002102 | podosome(GO:0002102) |
0.0 | 0.1 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.0 | 0.2 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.0 | 0.1 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.0 | 0.1 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.0 | 0.5 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.0 | 0.3 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.0 | 0.0 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
0.0 | 0.0 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
0.0 | 0.1 | GO:0042555 | MCM complex(GO:0042555) |
0.0 | 0.1 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.0 | 0.3 | GO:0031519 | PcG protein complex(GO:0031519) |
0.0 | 0.0 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.0 | 0.1 | GO:0070847 | core mediator complex(GO:0070847) |
0.0 | 0.0 | GO:0032279 | asymmetric synapse(GO:0032279) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.1 | 18.2 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
5.6 | 16.9 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
3.9 | 11.8 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
3.8 | 22.6 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
3.4 | 10.1 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
3.3 | 22.9 | GO:0003680 | AT DNA binding(GO:0003680) |
2.7 | 10.8 | GO:0001642 | group III metabotropic glutamate receptor activity(GO:0001642) |
2.6 | 7.7 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
2.5 | 12.3 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
2.3 | 27.9 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) |
1.9 | 7.7 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
1.9 | 13.4 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
1.9 | 5.7 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
1.9 | 11.3 | GO:0004385 | guanylate kinase activity(GO:0004385) |
1.8 | 7.2 | GO:1904288 | BAT3 complex binding(GO:1904288) |
1.7 | 5.2 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
1.7 | 13.8 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
1.6 | 4.8 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
1.5 | 7.6 | GO:0031849 | olfactory receptor binding(GO:0031849) |
1.4 | 4.3 | GO:0019959 | interleukin-8 binding(GO:0019959) |
1.4 | 8.7 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
1.4 | 4.2 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
1.4 | 5.6 | GO:0051425 | PTB domain binding(GO:0051425) |
1.4 | 5.5 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
1.3 | 5.3 | GO:0032551 | UTP binding(GO:0002134) pyrimidine ribonucleoside binding(GO:0032551) |
1.3 | 6.6 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
1.3 | 16.5 | GO:0031005 | filamin binding(GO:0031005) |
1.3 | 5.0 | GO:0004083 | bisphosphoglycerate 2-phosphatase activity(GO:0004083) |
1.2 | 3.7 | GO:0055100 | adiponectin binding(GO:0055100) |
1.2 | 3.7 | GO:0016822 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
1.2 | 6.0 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
1.2 | 3.6 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
1.1 | 4.4 | GO:0004849 | uridine kinase activity(GO:0004849) |
1.1 | 3.3 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
1.1 | 3.3 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
1.1 | 6.4 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
1.1 | 1.1 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
1.0 | 3.1 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
1.0 | 4.0 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
1.0 | 7.9 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
1.0 | 8.6 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.9 | 2.7 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.9 | 4.4 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.9 | 6.1 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
0.9 | 2.6 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.9 | 3.5 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.8 | 9.3 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.8 | 3.4 | GO:0030619 | U1 snRNA binding(GO:0030619) |
0.8 | 4.2 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.8 | 16.8 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.8 | 0.8 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.8 | 12.2 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.8 | 0.8 | GO:0005165 | neurotrophin receptor binding(GO:0005165) neurotrophin TRK receptor binding(GO:0005167) |
0.8 | 21.2 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.8 | 21.1 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.8 | 0.8 | GO:0003896 | DNA primase activity(GO:0003896) |
0.8 | 2.3 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
0.8 | 6.9 | GO:0038191 | neuropilin binding(GO:0038191) |
0.8 | 2.3 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.8 | 1.5 | GO:0008271 | secondary active sulfate transmembrane transporter activity(GO:0008271) |
0.8 | 3.0 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.8 | 3.0 | GO:0046870 | cadmium ion binding(GO:0046870) |
0.7 | 2.2 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
0.7 | 3.0 | GO:0005280 | hydrogen:amino acid symporter activity(GO:0005280) |
0.7 | 2.2 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.7 | 2.9 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.7 | 6.4 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
0.7 | 2.1 | GO:0042731 | PH domain binding(GO:0042731) |
0.7 | 4.2 | GO:0008199 | ferric iron binding(GO:0008199) |
0.7 | 5.6 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.7 | 3.5 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.7 | 7.6 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.7 | 3.4 | GO:0005283 | sodium:amino acid symporter activity(GO:0005283) |
0.7 | 2.1 | GO:0045503 | dynein light chain binding(GO:0045503) |
0.7 | 2.7 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.7 | 2.0 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
0.7 | 1.3 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
0.7 | 6.1 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.6 | 2.6 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
0.6 | 3.2 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.6 | 3.2 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.6 | 3.8 | GO:0034889 | alkyl sulfatase activity(GO:0018741) endosulfan hemisulfate sulfatase activity(GO:0034889) endosulfan sulfate hydrolase activity(GO:0034902) |
0.6 | 7.5 | GO:0003905 | alkylbase DNA N-glycosylase activity(GO:0003905) DNA-3-methylbase glycosylase activity(GO:0043733) |
0.6 | 2.5 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.6 | 1.8 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.6 | 1.2 | GO:0034618 | arginine binding(GO:0034618) |
0.6 | 1.7 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.6 | 1.7 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.6 | 1.7 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.6 | 13.8 | GO:0045296 | cadherin binding(GO:0045296) |
0.5 | 2.2 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.5 | 10.8 | GO:0003785 | actin monomer binding(GO:0003785) |
0.5 | 3.2 | GO:0002054 | nucleobase binding(GO:0002054) |
0.5 | 6.4 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
0.5 | 1.1 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.5 | 2.1 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.5 | 3.1 | GO:1990459 | transferrin receptor binding(GO:1990459) |
0.5 | 6.7 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.5 | 1.5 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
0.5 | 2.1 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.5 | 2.6 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.5 | 3.1 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.5 | 1.5 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.5 | 2.5 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.5 | 0.5 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.5 | 3.0 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.5 | 13.9 | GO:0050699 | WW domain binding(GO:0050699) |
0.5 | 3.9 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.5 | 1.4 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
0.5 | 0.5 | GO:0005119 | smoothened binding(GO:0005119) |
0.5 | 1.9 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.5 | 3.2 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.5 | 24.0 | GO:0017022 | myosin binding(GO:0017022) |
0.5 | 9.0 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.5 | 11.3 | GO:0004407 | histone deacetylase activity(GO:0004407) |
0.4 | 2.2 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.4 | 5.8 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.4 | 11.5 | GO:0005272 | sodium channel activity(GO:0005272) |
0.4 | 0.9 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.4 | 4.8 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.4 | 1.3 | GO:0019153 | protein-disulfide reductase (glutathione) activity(GO:0019153) |
0.4 | 0.4 | GO:0015087 | cobalt ion transmembrane transporter activity(GO:0015087) |
0.4 | 1.3 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
0.4 | 5.0 | GO:0016671 | oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor(GO:0016671) |
0.4 | 1.6 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.4 | 1.2 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.4 | 0.8 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.4 | 5.1 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.4 | 4.3 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.4 | 1.2 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
0.4 | 11.3 | GO:0016667 | oxidoreductase activity, acting on a sulfur group of donors(GO:0016667) |
0.4 | 1.9 | GO:0045545 | syndecan binding(GO:0045545) |
0.4 | 3.5 | GO:0051393 | alpha-actinin binding(GO:0051393) |
0.4 | 1.5 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.4 | 0.8 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.4 | 1.5 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.4 | 4.3 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.3 | 2.1 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.3 | 0.7 | GO:0017002 | activin-activated receptor activity(GO:0017002) |
0.3 | 3.4 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.3 | 2.0 | GO:0016595 | glutamate binding(GO:0016595) |
0.3 | 9.0 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.3 | 3.0 | GO:0004970 | ionotropic glutamate receptor activity(GO:0004970) |
0.3 | 1.3 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.3 | 1.7 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.3 | 8.0 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.3 | 1.3 | GO:0034548 | N-cyclopropylmelamine deaminase activity(GO:0034547) N-cyclopropylammeline deaminase activity(GO:0034548) N-cyclopropylammelide alkylamino hydrolase activity(GO:0034549) 2,5-diamino-6-ribitylamino-4(3H)-pyrimidinone 5'-phosphate deaminase activity(GO:0043723) tRNA-specific adenosine-37 deaminase activity(GO:0043829) archaeal-specific GTP cyclohydrolase activity(GO:0044682) tRNA-specific adenosine-34 deaminase activity(GO:0052717) |
0.3 | 1.0 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.3 | 7.7 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
0.3 | 1.3 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.3 | 0.9 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.3 | 0.3 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.3 | 3.8 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.3 | 1.3 | GO:0034584 | piRNA binding(GO:0034584) |
0.3 | 0.9 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.3 | 0.9 | GO:0004854 | xanthine dehydrogenase activity(GO:0004854) oxidoreductase activity, acting on CH or CH2 groups, NAD or NADP as acceptor(GO:0016726) |
0.3 | 2.4 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.3 | 0.9 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.3 | 0.9 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
0.3 | 3.3 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.3 | 1.2 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.3 | 1.2 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.3 | 0.3 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
0.3 | 2.6 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.3 | 3.7 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.3 | 0.9 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.3 | 18.3 | GO:0005262 | calcium channel activity(GO:0005262) |
0.3 | 1.4 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.3 | 4.2 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.3 | 3.1 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.3 | 0.8 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.3 | 1.4 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.3 | 0.8 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
0.3 | 4.1 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.3 | 0.8 | GO:0004748 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.3 | 1.1 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.3 | 5.3 | GO:0030332 | cyclin binding(GO:0030332) |
0.3 | 1.8 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
0.3 | 1.3 | GO:0034711 | inhibin binding(GO:0034711) |
0.3 | 1.6 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.3 | 1.3 | GO:0039706 | co-receptor binding(GO:0039706) |
0.3 | 2.6 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.3 | 0.5 | GO:0033677 | DNA/RNA helicase activity(GO:0033677) |
0.3 | 0.5 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
0.3 | 1.0 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.3 | 1.3 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.2 | 7.5 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.2 | 1.7 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.2 | 2.0 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.2 | 0.7 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.2 | 4.9 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.2 | 0.7 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.2 | 2.2 | GO:0034847 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
0.2 | 3.1 | GO:0030275 | LRR domain binding(GO:0030275) |
0.2 | 10.2 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.2 | 7.3 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.2 | 0.9 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.2 | 0.5 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.2 | 3.9 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.2 | 0.9 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.2 | 0.2 | GO:0016743 | carboxyl- or carbamoyltransferase activity(GO:0016743) |
0.2 | 3.6 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.2 | 3.3 | GO:0016638 | oxidoreductase activity, acting on the CH-NH2 group of donors(GO:0016638) |
0.2 | 1.1 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.2 | 3.5 | GO:0008373 | sialyltransferase activity(GO:0008373) |
0.2 | 1.1 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.2 | 0.6 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.2 | 0.6 | GO:0019958 | C-X-C chemokine binding(GO:0019958) |
0.2 | 0.8 | GO:0030274 | LIM domain binding(GO:0030274) |
0.2 | 0.6 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.2 | 0.8 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.2 | 5.2 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.2 | 0.6 | GO:0097506 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
0.2 | 0.6 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.2 | 1.2 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
0.2 | 0.4 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.2 | 1.4 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.2 | 2.3 | GO:0016303 | 1-phosphatidylinositol-3-kinase activity(GO:0016303) |
0.2 | 0.6 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.2 | 0.8 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.2 | 3.0 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.2 | 0.8 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.2 | 0.8 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.2 | 1.0 | GO:0016934 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.2 | 0.6 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.2 | 1.2 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.2 | 2.3 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.2 | 1.1 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.2 | 1.5 | GO:0043855 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) cyclic nucleotide-gated ion channel activity(GO:0043855) |
0.2 | 1.1 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.2 | 0.6 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.2 | 0.6 | GO:0015119 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.2 | 17.3 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.2 | 0.5 | GO:0016151 | nickel cation binding(GO:0016151) |
0.2 | 1.6 | GO:0042834 | peptidoglycan binding(GO:0042834) |
0.2 | 0.5 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
0.2 | 0.9 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.2 | 0.5 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.2 | 1.5 | GO:0030553 | cGMP binding(GO:0030553) |
0.2 | 10.9 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.2 | 1.0 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.2 | 2.1 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.2 | 1.1 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.2 | 0.5 | GO:1990189 | peptide-serine-N-acetyltransferase activity(GO:1990189) peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
0.2 | 0.6 | GO:0003840 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
0.2 | 0.6 | GO:0098988 | G-protein coupled glutamate receptor activity(GO:0098988) |
0.2 | 0.5 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.2 | 0.6 | GO:0005113 | patched binding(GO:0005113) |
0.2 | 2.0 | GO:0000146 | microfilament motor activity(GO:0000146) |
0.2 | 4.6 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.2 | 0.6 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
0.1 | 0.7 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
0.1 | 0.3 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.1 | 12.4 | GO:0051015 | actin filament binding(GO:0051015) |
0.1 | 0.4 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.1 | 0.7 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.1 | 3.2 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.1 | 0.4 | GO:0016015 | morphogen activity(GO:0016015) |
0.1 | 1.2 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.1 | 0.6 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.1 | 1.1 | GO:0015211 | purine nucleoside transmembrane transporter activity(GO:0015211) |
0.1 | 0.7 | GO:0004556 | alpha-amylase activity(GO:0004556) |
0.1 | 1.1 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.1 | 0.1 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
0.1 | 2.9 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.1 | 0.5 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.1 | 0.8 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.1 | 1.6 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.1 | 0.9 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.1 | 3.5 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
0.1 | 0.4 | GO:0038100 | nodal binding(GO:0038100) |
0.1 | 1.8 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.1 | 0.8 | GO:0004064 | arylesterase activity(GO:0004064) |
0.1 | 2.5 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.1 | 1.9 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.1 | 0.5 | GO:0052851 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.1 | 2.6 | GO:0015928 | fucosidase activity(GO:0015928) |
0.1 | 1.7 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.1 | 0.6 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.1 | 0.4 | GO:0031014 | troponin T binding(GO:0031014) |
0.1 | 0.5 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.1 | 0.3 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.1 | 0.3 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.1 | 0.3 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
0.1 | 0.3 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.1 | 0.2 | GO:0010853 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.1 | 0.3 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.1 | 0.3 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.1 | 0.7 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.1 | 0.2 | GO:0030519 | snoRNP binding(GO:0030519) |
0.1 | 1.9 | GO:0015301 | anion:anion antiporter activity(GO:0015301) |
0.1 | 0.3 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
0.1 | 0.3 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.1 | 0.2 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.1 | 0.2 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.1 | 4.8 | GO:0001227 | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001227) |
0.1 | 0.2 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
0.1 | 3.1 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
0.1 | 0.4 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.1 | 0.1 | GO:0030911 | TPR domain binding(GO:0030911) |
0.1 | 2.6 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.1 | 2.0 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.1 | 0.7 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.1 | 0.6 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.1 | 1.1 | GO:0022841 | leak channel activity(GO:0022840) potassium ion leak channel activity(GO:0022841) narrow pore channel activity(GO:0022842) |
0.1 | 2.4 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.1 | 3.1 | GO:0008081 | phosphoric diester hydrolase activity(GO:0008081) |
0.1 | 3.2 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.1 | 0.3 | GO:0050544 | arachidonic acid binding(GO:0050544) |
0.1 | 0.2 | GO:0034046 | poly(G) binding(GO:0034046) |
0.1 | 0.5 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.1 | 5.0 | GO:0004004 | ATP-dependent RNA helicase activity(GO:0004004) RNA-dependent ATPase activity(GO:0008186) |
0.1 | 0.5 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.1 | 1.1 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.1 | 0.3 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.1 | 0.2 | GO:0036137 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
0.1 | 0.3 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.1 | 0.3 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
0.1 | 1.1 | GO:0015643 | toxic substance binding(GO:0015643) |
0.1 | 0.4 | GO:0052724 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
0.1 | 2.0 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.1 | 0.2 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
0.1 | 0.5 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.1 | 0.7 | GO:0031386 | protein tag(GO:0031386) |
0.1 | 0.4 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.1 | 0.2 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.1 | 1.3 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
0.1 | 0.1 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
0.1 | 0.1 | GO:0016160 | amylase activity(GO:0016160) |
0.1 | 0.4 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.1 | 0.2 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.1 | 33.7 | GO:0005509 | calcium ion binding(GO:0005509) |
0.1 | 0.2 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.1 | 0.2 | GO:2001069 | glycogen binding(GO:2001069) |
0.1 | 0.2 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.1 | 0.2 | GO:0015232 | heme transporter activity(GO:0015232) |
0.1 | 2.3 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.1 | 0.1 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.1 | 1.6 | GO:0001191 | transcriptional repressor activity, RNA polymerase II transcription factor binding(GO:0001191) |
0.1 | 0.5 | GO:0016725 | oxidoreductase activity, acting on CH or CH2 groups(GO:0016725) |
0.1 | 0.1 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
0.1 | 0.4 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.1 | 0.4 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) |
0.1 | 0.8 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.1 | 0.6 | GO:0034951 | pivalyl-CoA mutase activity(GO:0034784) o-hydroxylaminobenzoate mutase activity(GO:0034951) lupeol synthase activity(GO:0042299) beta-amyrin synthase activity(GO:0042300) baruol synthase activity(GO:0080011) |
0.1 | 0.4 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.1 | 0.2 | GO:0016892 | endoribonuclease activity, producing 3'-phosphomonoesters(GO:0016892) |
0.1 | 0.3 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.1 | 0.2 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.1 | 0.2 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.1 | 0.4 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.1 | 0.7 | GO:0070628 | proteasome binding(GO:0070628) |
0.1 | 0.1 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.1 | 0.1 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
0.1 | 0.2 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.1 | 0.1 | GO:0035939 | microsatellite binding(GO:0035939) |
0.1 | 0.1 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.1 | 0.2 | GO:0019956 | chemokine binding(GO:0019956) |
0.1 | 0.2 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.1 | 1.3 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) |
0.1 | 0.8 | GO:0005351 | sugar:proton symporter activity(GO:0005351) |
0.1 | 0.3 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.1 | 0.6 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.1 | 0.2 | GO:0080130 | L-phenylalanine:2-oxoglutarate aminotransferase activity(GO:0080130) |
0.1 | 1.4 | GO:0005109 | frizzled binding(GO:0005109) |
0.1 | 0.2 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.1 | 0.2 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.0 | 0.0 | GO:0010858 | calcium-dependent protein kinase regulator activity(GO:0010858) |
0.0 | 0.8 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.0 | 3.9 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.0 | 0.2 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.0 | 0.1 | GO:0046790 | virion binding(GO:0046790) |
0.0 | 0.1 | GO:0047751 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.0 | 0.4 | GO:0032296 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
0.0 | 0.9 | GO:0016676 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.0 | 1.1 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
0.0 | 0.3 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.0 | 0.1 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.0 | 0.4 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.0 | 0.4 | GO:0001608 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.0 | 0.1 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.0 | 0.1 | GO:0030350 | iron-responsive element binding(GO:0030350) |
0.0 | 0.1 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.0 | 0.9 | GO:0052770 | coenzyme F390-A hydrolase activity(GO:0052770) coenzyme F390-G hydrolase activity(GO:0052771) |
0.0 | 0.1 | GO:0032564 | dATP binding(GO:0032564) |
0.0 | 0.3 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.0 | 0.1 | GO:0004466 | long-chain-acyl-CoA dehydrogenase activity(GO:0004466) |
0.0 | 0.2 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.0 | 0.1 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.0 | 0.1 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.0 | 0.1 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.0 | 0.8 | GO:0017046 | peptide hormone binding(GO:0017046) |
0.0 | 0.3 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.0 | 0.0 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.0 | 0.1 | GO:0008808 | cardiolipin synthase activity(GO:0008808) phosphatidyltransferase activity(GO:0030572) |
0.0 | 0.1 | GO:0034912 | enoyl-[acyl-carrier-protein] reductase activity(GO:0016631) 2,3-dihydroxy-2,3-dihydro-phenylpropionate dehydrogenase activity(GO:0018498) cis-2,3-dihydrodiol DDT dehydrogenase activity(GO:0018499) trans-9R,10R-dihydrodiolphenanthrene dehydrogenase activity(GO:0018500) cis-chlorobenzene dihydrodiol dehydrogenase activity(GO:0018501) 2,5-dichloro-2,5-cyclohexadiene-1,4-diol dehydrogenase activity(GO:0018502) trans-1,2-dihydrodiolphenanthrene dehydrogenase activity(GO:0018503) 3,4-dihydroxy-3,4-dihydrofluorene dehydrogenase activity(GO:0034790) benzo(a)pyrene-trans-11,12-dihydrodiol dehydrogenase activity(GO:0034805) benzo(a)pyrene-cis-4,5-dihydrodiol dehydrogenase activity(GO:0034809) citronellyl-CoA dehydrogenase activity(GO:0034824) menthone dehydrogenase activity(GO:0034838) phthalate 3,4-cis-dihydrodiol dehydrogenase activity(GO:0034912) cinnamate reductase activity(GO:0043786) NADPH-dependent curcumin reductase activity(GO:0052849) NADPH-dependent dihydrocurcumin reductase activity(GO:0052850) |
0.0 | 0.2 | GO:0035254 | glutamate receptor binding(GO:0035254) |
0.0 | 0.0 | GO:0032557 | pyrimidine ribonucleotide binding(GO:0032557) |
0.0 | 0.0 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.0 | 0.0 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.0 | 0.3 | GO:1901505 | carbohydrate derivative transporter activity(GO:1901505) |
0.0 | 0.4 | GO:0035410 | dihydrotestosterone 17-beta-dehydrogenase activity(GO:0035410) |
0.0 | 0.0 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.0 | 0.3 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.0 | 0.1 | GO:0004802 | transketolase activity(GO:0004802) |
0.0 | 0.1 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.0 | 0.1 | GO:0030345 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
0.0 | 0.2 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
0.0 | 0.0 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.0 | 0.1 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.0 | 0.0 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.0 | 0.1 | GO:0016937 | short-branched-chain-acyl-CoA dehydrogenase activity(GO:0016937) |
0.0 | 0.1 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.0 | 0.1 | GO:0019863 | IgE binding(GO:0019863) |
0.0 | 0.1 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.0 | 0.0 | GO:0015927 | trehalase activity(GO:0015927) |
0.0 | 0.1 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.0 | 0.1 | GO:0004365 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.0 | 0.0 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.0 | 0.2 | GO:0005267 | potassium channel activity(GO:0005267) |
0.0 | 6.6 | GO:0005549 | odorant binding(GO:0005549) |
0.0 | 0.0 | GO:0008142 | oxysterol binding(GO:0008142) |
0.0 | 0.0 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.0 | 0.0 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.0 | 0.6 | GO:0019843 | rRNA binding(GO:0019843) |
0.0 | 0.3 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.0 | 0.0 | GO:0050786 | RAGE receptor binding(GO:0050786) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.5 | 1.5 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
1.0 | 2.9 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.9 | 13.0 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.7 | 0.7 | ST ADRENERGIC | Adrenergic Pathway |
0.6 | 10.1 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.5 | 16.8 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.5 | 6.5 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.4 | 0.9 | PID REELIN PATHWAY | Reelin signaling pathway |
0.4 | 2.0 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.3 | 6.7 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.3 | 4.3 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.3 | 8.1 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.3 | 3.6 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.3 | 4.0 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.2 | 0.7 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.2 | 5.1 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.2 | 6.5 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.2 | 6.7 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.2 | 9.0 | PID LKB1 PATHWAY | LKB1 signaling events |
0.2 | 11.9 | PID CDC42 PATHWAY | CDC42 signaling events |
0.2 | 0.4 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.2 | 0.4 | PID IGF1 PATHWAY | IGF1 pathway |
0.2 | 2.6 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.2 | 5.0 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.2 | 0.4 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.2 | 2.6 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.2 | 2.7 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.2 | 26.5 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.2 | 3.7 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.1 | 6.5 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.1 | 1.0 | ST STAT3 PATHWAY | STAT3 Pathway |
0.1 | 0.3 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.1 | 2.7 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.1 | 2.9 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.1 | 0.1 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.1 | 0.3 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.1 | 0.8 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.1 | 0.6 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.1 | 2.4 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.1 | 1.0 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.1 | 3.3 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.1 | 2.7 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.1 | 0.6 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.1 | 0.4 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.1 | 25.3 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.1 | 0.5 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.1 | 0.7 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.1 | 1.5 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.1 | 0.9 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.1 | 0.5 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.1 | 1.1 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.1 | 0.1 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.1 | 1.4 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.1 | 2.8 | PID ATR PATHWAY | ATR signaling pathway |
0.1 | 1.0 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.1 | 0.1 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.0 | 0.1 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.0 | 0.0 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.0 | 0.6 | PID MYC PATHWAY | C-MYC pathway |
0.0 | 0.3 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.0 | 3.4 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 0.0 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.0 | 0.0 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.0 | 0.0 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.0 | 0.1 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.0 | 0.1 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.7 | 22.7 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
1.7 | 23.7 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
1.5 | 33.6 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
1.3 | 1.3 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
1.2 | 8.2 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
1.1 | 8.8 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
1.0 | 2.1 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
1.0 | 10.8 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.9 | 12.7 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.9 | 16.3 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.9 | 2.7 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.8 | 14.3 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.8 | 9.0 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.8 | 0.8 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
0.8 | 11.4 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.5 | 5.6 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.5 | 3.2 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.5 | 0.9 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.4 | 0.4 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.4 | 18.9 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.4 | 1.7 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.4 | 8.0 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.4 | 8.0 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.4 | 9.9 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.4 | 6.2 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.4 | 3.8 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.4 | 15.4 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
0.4 | 0.7 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
0.4 | 4.7 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.4 | 6.4 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.3 | 10.8 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.3 | 5.9 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.3 | 1.0 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.3 | 6.6 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.3 | 4.3 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.3 | 4.5 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.3 | 3.5 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.3 | 4.3 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.3 | 2.8 | REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
0.3 | 0.5 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
0.3 | 2.6 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.3 | 0.5 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |
0.3 | 2.0 | REACTOME PLATELET HOMEOSTASIS | Genes involved in Platelet homeostasis |
0.3 | 0.8 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.2 | 4.5 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.2 | 2.6 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.2 | 0.7 | REACTOME CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE | Genes involved in Cell death signalling via NRAGE, NRIF and NADE |
0.2 | 1.4 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.2 | 3.6 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
0.2 | 3.9 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
0.2 | 1.9 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.2 | 3.1 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.2 | 3.9 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.2 | 2.2 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.2 | 2.0 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.2 | 8.8 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.2 | 1.1 | REACTOME CA DEPENDENT EVENTS | Genes involved in Ca-dependent events |
0.2 | 5.7 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.2 | 1.7 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.2 | 3.9 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.2 | 1.7 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.2 | 0.7 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.2 | 1.3 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.2 | 3.7 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.2 | 0.2 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
0.2 | 1.9 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.2 | 0.6 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.2 | 1.5 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.1 | 1.6 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.1 | 0.1 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.1 | 2.0 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.1 | 0.1 | REACTOME CDT1 ASSOCIATION WITH THE CDC6 ORC ORIGIN COMPLEX | Genes involved in CDT1 association with the CDC6:ORC:origin complex |
0.1 | 2.2 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.1 | 1.3 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.1 | 1.1 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.1 | 0.1 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.1 | 0.1 | REACTOME MITOTIC M M G1 PHASES | Genes involved in Mitotic M-M/G1 phases |
0.1 | 0.9 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.1 | 0.4 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.1 | 1.1 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.1 | 1.1 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.1 | 6.0 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.1 | 0.8 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.1 | 1.3 | REACTOME TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX | Genes involved in TRAF6 mediated induction of TAK1 complex |
0.1 | 0.6 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.1 | 0.7 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.1 | 0.3 | REACTOME INHIBITION OF THE PROTEOLYTIC ACTIVITY OF APC C REQUIRED FOR THE ONSET OF ANAPHASE BY MITOTIC SPINDLE CHECKPOINT COMPONENTS | Genes involved in Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components |
0.1 | 2.6 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.1 | 1.4 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.1 | 3.0 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.1 | 3.4 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.1 | 0.3 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.1 | 0.9 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.1 | 1.5 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.1 | 3.4 | REACTOME L1CAM INTERACTIONS | Genes involved in L1CAM interactions |
0.1 | 1.0 | REACTOME VIRAL MESSENGER RNA SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
0.1 | 0.3 | REACTOME SHC RELATED EVENTS | Genes involved in SHC-related events |
0.1 | 1.7 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.1 | 0.2 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
0.1 | 0.9 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.1 | 0.6 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.1 | 1.0 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.1 | 1.7 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.1 | 0.4 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.1 | 1.7 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.1 | 1.1 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.1 | 0.1 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.1 | 0.1 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.1 | 1.2 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.1 | 0.7 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.1 | 0.1 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.1 | 0.4 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
0.1 | 0.6 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
0.1 | 0.1 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.1 | 0.3 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.1 | 0.6 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.0 | 0.3 | REACTOME SHC MEDIATED CASCADE | Genes involved in SHC-mediated cascade |
0.0 | 0.6 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.0 | 0.5 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.0 | 0.8 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.0 | 1.0 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.0 | 0.2 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.0 | 0.4 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.0 | 0.2 | REACTOME RNA POL III TRANSCRIPTION | Genes involved in RNA Polymerase III Transcription |
0.0 | 0.1 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.0 | 0.3 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.0 | 0.6 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.0 | 0.1 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.0 | 0.2 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.0 | 0.1 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.0 | 0.8 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.0 | 0.4 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.0 | 0.2 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.0 | 0.0 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.0 | 0.0 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.0 | 0.0 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.0 | 0.0 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.0 | 0.7 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.0 | 0.5 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.0 | 0.1 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.0 | 0.1 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.0 | 0.2 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |